Zoekresultaten - You searched for 1

1826 results

IQVIA, QbD and Select enter into a strategic partnership with flanders.bio as of January 1st, 2019

Read more

ActoBio Therapeutics™ Progresses AG019 to Next Stage of a Phase Ib/IIa Clinical Study for the Treatment of Type 1 Diabetes

Read more

ActoBio Therapeutics Greenlighted by FDA to Commence a Phase Ib/IIa Trial with AG019 for the Treatment of Early Onset Type 1 Diabetes

Read more

State of the Union 2017

Read more

knowledge for growth 2017

Read more

argenx to provide updates on Phase 1/2 clinical trials of ARGX-110 in Acute Myeloid Leukemia and Cutaneous T-Cell Lymphoma during American Society of Hematology Annual Meeting

Read more

ActoBio Therapeutics™ Doses First Patient in Phase Ib/IIa Clinical Study of AG019 for the Treatment of Type 1 Diabetes

Read more

Aphea.Bio is awarded a 1.2Mi€ grant from VLAIO to further expand its activities

Read more

GILEAD AND GALAPAGOS ANNOUNCE FILGOTINIB MEETS PRIMARY AND KEY SECONDARY ENDPOINTS IN THE PHASE 3 FINCH 1 RHEUMATOID ARTHRITIS STUDY

Read more

Oxurion NV announces full enrollment in its Phase 1 trial evaluating the safety of its plasma kallikrein inhibitor THR-149 for treatment of DME, ahead of schedule

Read more

Wanted: 18,200 highly skilled profiles for bottleneck sectors

Read more

Oxurion NV Reports Positive Topline Phase 1 Results with THR-149, a novel, potent plasma kallikrein inhibitor for the treatment

Read more

13th International Conference on Renewable Resources & Biorefineries

Read more

Market of 105 billion euros open to Flemish biotech companies

Read more

Imec Introduces CMOS Chip With 16,384 Micro-electrodes and 1,024 Channels for Multimodal Cell Interfacing

Read more

Argenx to host conference call & webcast to report fourth quarter business update and full year 2017 financial results on March 1, 2018

Read more

Promethera Biosciences Acquires Baliopharm AG to Strengthen its Therapeutic Strategy in NASH With a Unique Tumor Necrosis Factor Receptor 1 (TNF-R1) Antibody Drug Candidates

Read more

CoBioRes receives a € 1.7M grant from VLAIO to support its tetrapeptide prodrug research for treatment of Triple Negative Breast Cancer

Read more

argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia

Read more

reMYND raises 12 million EUR to assess clinical proof-ofmechanism in Alzheimer’s and to expand into orphan disorders

Read more

Galapagos starts first Phase 1 trial with Toledo compound

Read more

Biocartis Places Its 1,000th Idylla(TM) Instrument with Geisinger in US

Read more

PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019

Read more

TiGenix to participate in key investor conferences in April 2017

Read more

Flanders @ BIO International Convention 2017

Read more

argenx receives first preclinical milestone payment in AbbVie collaboration

Read more

ESPERITE's shareholders approved the external financing of up to EUR 13 million

Read more

Smart Implant & (Bio-)medical Imaging Platform Meeting

Read more

ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017

Read more

Publication in accordance with article 14 of the law of May 2007 regarding the publication of major shareholdings (the "Transparency Law")

Read more

flanders.bio's flagship event knowledge for growth 2018

Read more

Galapagos and MorphoSys report first promising signs of clinical activity in a Phase 1 study with IL-17C antibody MOR106 in atopic dermatitis patients

Read more

ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital

Read more

12th Conference on Protein Stabilization (ProtStab 2018)

Read more

Galapagos and MorphoSys present results from a Phase 1 study with MOR106 in atopic dermatitis as late-breaking abstract at the American Academy of Dermatology (AAD) meeting in San Diego

Read more

Biocartis Group NV: Biocartis kondigt 2017 financiële resultaten aan via webcast op 1 maart 2018

Read more

Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement

Read more

eTheRNA completes enrolment of low dose cohort for Phase 1b study of TriMix mRNA-based cancer specific immunotherapy (ECI-006) in melanoma

Read more

TiGenix Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

Read more

Ablynx publication in accordance with article 14 of the belgian law of 2 may 2007

Read more

ThromboGenics Enrolls First Patient in Phase 1 Clinical Study Evaluating THR-149

Read more

Imec demonstrates compact low-power 140GHz CMOS radar with on-chip antennas

Read more

Mithra Announces Presentation of Donesta® Results at the International Menopause Society’s 16th World Congress

Read more

ThromboGenics Reports Day 150 Topline Data from its Phase 1/2 Clinical Study

Read more

argenx announces publication of full data from Phase 1 healthy volunteer study of efgartigimod in Journal of Clinical Investigation

Read more

Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106

Read more

Oxurion Enrolls First Patient in Phase 2 Clinical Study Evaluating THR-317 (anti-PlGF) for treatment of Idiopathic Macular Telangiectasia Type 1 (MacTel 1)

Read more

Mithra reduces environmental impact of CDMO facility in Belgium with the installation of 1800 solar panels

Read more

European Biotech Week

Read more

Innovation for Health 2020

Read more

CMAST is stepping into a strategic partnership with FlandersBio

Read more

The Future of Health Technology: Lab on Chip & Diagnostics platform meeting

Read more

Galapagos increases share capital through warrant exercises

Read more

Belgium showcases expertise on Immunotherapy at the world’s largest Biotechnology Conference – San Diego, June 19- 23, 2017

Read more

Publication in accordance with art. 14 of the Belgian Law regarding the publication of major shareholdings (the "transparancy law")

Read more

Ablynx: publication in accordance with article 14 of the Belgian law regarding the publication of major shareholdings

Read more

OPINNO educational module: What does it take to work in a life sciences company?

Read more

OPINNO BioBizz Café Ghent

Read more

argenx to host KOL breakfast symposium on pemphigus vulgaris on November 10, 2017

Read more

Galapagos initiates Phase 1 study with novel CF corrector GLPG3221

Read more

Rewind Therapeutics secures 15.2 M EURO to develop novel remyelination therapies

Read more

Confo Therapeutics is awarded a EUR 1M grant to increase its screening capabilities

Read more

Convert Pharmaceuticals secures EUR 13,6 million to develop anti-cancer drugs

Read more

TiGenix: Transparantiekennisgevingen overeenkomstig Artikel 14 van de wet van 2 mei 2007

Read more

argenx announces data from Phase 1 study of efgartigimod (ARGX-113) subcutaneous formulation demonstrating comparable characteristics to intravenous formulation

Read more

Oxurion nv Enrolls First Patient in Phase 1 Clinical Trial Evaluating THR-687, a Novel Pan-RGD Integrin Antagonist, for Treatment of DME

Read more

flanders.bio's flagship event knowledge for growth 2019

Read more

Galapagos: Topline interim results of FALCON trial Part 1 in CF

Read more

MDxHealth (R): MDxHealth Signs Partnership with LifeLabs to Make SelectMDx available in Canada

Read more

Sequana Medical NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES

Read more

MDxHealth Appoints Michael K. McGarrity as CEO

Read more

Kiadis Pharma’s Pediatric Investigation Plan for ATIR101™ accepted by the European Medicines Agency’s Pediatric Committee

Read more

Kiadis Pharma announces Annual Results for the year ended December 31, 2016

Read more

Galapagos announces three new Phase 2 Proof-of-Concept studies with filgotinib

Read more

TiGenix reports 2016 full year results

Read more

Applied Bioinformatics in Life Sciences (2nd edition)

Read more

Galapagos raises $338 million gross proceeds in a U.S. public offering

Read more

Galapagos announces launch of proposed public offering

Read more

Ablynx announces warrant exercise

Read more

State of the Union 2018

Read more

Ablynx: publication regarding the publication of major shareholdings

Read more

TiGenix Transparency notification pursuant to Article 14 of the Law of May 2, 2007

Read more

TiGenix - Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

Read more

MDxHealth Notice of Financial Year 2017 Results

Read more

CMAST to present at a Veeva seminar on modernizing quality management / April 10th, 2018 / Paris, France

Read more

argenx to host KOL breakfast symposium on immune thrombocytopenia on June 19, 2018

Read more

BioSeed 2019

Read more

Blockbuster Potential in Perimenopause with new E4 Candidate and Acceleration of Donesta Phase III Program

Read more

Imec and CARDIS Partners Develop Unique Photonic-Based Medical Device for the Screening

Read more

MDxHealth Announces Presentation of Positive Data for SelectMDx and ConfirmMDx in Prostate Cancer Diagnosis

Read more

ProPharma Group Announces the Acquisition of Southwood Research

Read more

MDxHealth Announces Positive Data from Pan-European Clinical Validation Study of SelectMDx

Read more

BCF Career Event

Read more

Getting your fundamentals right to ensure fast growth

Read more

ActoBio Therapeutics™’ CTO Lothar Steidler Elected VIB Alumni Awardee 2019

Read more

MDxHealth (R): Multi-center Study Validates SelectMDx's High Negative Predictive Value and Sensitivity

Read more

Immunity for Health

Read more

PMV: Belgian Growth Fund gaat van start met initieel bedrag van 213 miljoen euro

Read more

Flanders @ BioJapan 2019: Flemish Life Sciences & Biotech Week

Read more

Galapagos: Publication of the annual report

Read more

Imec to Honor Samsung’s Dr. Kinam Kim With “Lifetime of Innovation Award”

Read more

BioBase4SME biedt biogebaseerde start-ups en KMO’s een kostenloze, intensieve business training voor succesvol innoveren aan

Read more

Argenx launches Phase II study of ARGX-110 as a monotherapy in relapsed/refractory CTCL patients

Read more

BCF Career Event - Utrecht

Read more

3th BMIC Congress

Read more

Life sciences remuneration seminar

Read more

Bio€quity Europe 2017

Read more

Nordic Life Science Days 2017

Read more

BCF Career Event - Ghent

Read more

Mithra Pharmaceuticals publie son rapport annuel 2016 et l’invitation à son Assemblée Générale Ordinaire des actionnaires

Read more

REVERSED BREXIT: £250 MILLION FOR BART DE STROOPER'S DEMENTIA RESEARCH

Read more

Biogazelle offers unique mRNA sequencing on plasma

Read more

Biocartis Group NV: Disclosure of a transparency notification

Read more

Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €363.9 million

Read more

Esperite (ESP), The Cell Factory demonstrate anti-inflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy

Read more

TiGenix to present at the Crohn's and Colitis Foundation's Novel Technologies in Inflammatory Bowel Disease workshop in New York

Read more

TiGenix to present at Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas

Read more

Biocartis Group NV: Results of the annual shareholders' meeting held on 12 May 2017

Read more

MDxHealth Shareholder Transparency Notification

Read more

Wereldprimeur: proefbuisveulen geboren uit onrijpe ingevroren eicel

Read more

Galapagos creates new warrant plan

Read more

Mithra Obtains Marketing Authorization for Tibelia® in France

Read more

TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure

Read more

OPINNO

Read more

Biocartis Group NV: Results of the extraordinary shareholders' meeting held on 11 September 2017

Read more

Presentation of the results of flanders.bio's annual (Bio)Pharma Salary Survey

Read more

OPINNO BioBizz Café Antwerp

Read more

flanders.bio's Healthcare Leaders Dinner

Read more

Biocartis - Disclosure of a transparency notification

Read more

MDxHealth's New Share Capital Amount and New Number of Shares

Read more

GST raises EUR 5 million to develop veterinary stem cell products

Read more

Biocartis Group NV: Biocartis and Nichirei Bioscience Announce Commercialization Collaboration for Japanese Market

Read more

Start2pharma 2-days: CGMP & QMS for professionals with 0 – 2 years’ experience in the industry

Read more

SelectMDx Outperforms Prostate Health Index (phi) Blood Test for Detecting High-Grade Prostate Cancer

Read more

ProPharma Group Announces the Acquisition of The Weinberg Group

Read more

Mithra Announces Positive Top-line Results of Estelle® Phase III Oral Contraceptive Study in U.S/Canada

Read more

FAIRplus: new project to improve data sharing and reuse in life sciences research

Read more

Sequana Medical raises €27.5 million in successful Initial Public Offering

Read more

First patient recruited in collaborative Phase 1 study to evaluate TriMix in breast cancer patients

Read more

Baanbrekende Radarchip maakt Gebouwen Slimmer

Read more

Janssen Pharmaceutica wil meisjes enthousiasmeren voor technologie en wetenschap

Read more

Genkyotex Reverse Stock Split Takes Effect

Read more

GILEAD AND GALAPAGOS REPORT UPDATED SAFETY INFORMATION FOR FILGOTINIB IN RHEUMATOID ARTHRITIS (RA)

Read more

V-Bio Ventures leads AgomAb Therapeutics’ 21m EUR series A financing round

Read more

GSK meets Belgian universities: Regional scientific associations bring together researchers from industry and universities

Read more

Scientists (dis)solve a century-long mystery to treat asthma and airway inflammation

Read more

The future of healthcare is digital

Read more

Hot in Healthcare

Read more

Bone Therapeutics’ allogeneic cell therapy product, ALLOB, meets primary endpoints in Phase IIa

Read more

Bone Therapeutics successfully raises EUR 8.5 million

Read more

AgroSavfe appoints Patrice Sellès as new Chief Executive Officer and further strengthens leadership team

Read more

DXpx conference, Düsseldorf

Read more

Celyad Reports 2016 Financial and Operating Results and Expected Key Milestones for 2017

Read more

Kiadis Pharma announces positive regulatory update on ATIR101™ and ATIR201™

Read more

New Study Shows MDxHealth's SelectMDx Test is Cost-Effective for Biopsy Selection

Read more

Biocartis Group NV: Oproeping tot de gewone algemene aandeelhoudersvergadering

Read more

Epilog lanceert Epilog PreOp, een geautomatiseerde tool voor pre-operatieve EEG analyse

Read more

RegMed

Read more

Phase Transitions in Biology and Disease

Read more

EARLY PHASE DRUG DEVELOPMENT COURSE - FUTURE MEANS CREATIVITY

Read more

Bio-Based Live Europe : Creating sustainable products from bio-based innovations

Read more

At The Forefront Of Plant Research

Read more

Specialized blood vessels enhance tumor-fighting immunotherapy

Read more

argenx files registration statement for a proposed public offering in the United States

Read more

Kinesis Pharma fully integrated & operative under Venn Life Science Brand

Read more

BioPharm America™ 2017 - 10th Annual International Partnering Conference

Read more

Galapagos reports first quarter 2017 results

Read more

Esperite (ESP): Patent granted in China for treatment of acute and chronic inflammatory and autoimmune diseases with EVs technology

Read more

Galapagos NV: Seven abstracts on filgotinib accepted by EULAR 2017

Read more

Kiadis Pharma raises €5 million in private placement with institutional investors

Read more

Kempen & Co appoints Jan De Kerpel as Managing Director Life Sciences

Read more

ConfirmMDx Study Provides Further Validation of Epigenetic Risk Profile

Read more

MDxHealth Announces First Half 2017 Financial Results

Read more

flanders.bio - CMAST Partner Day: Realizing Life Science Innovation with Impact

Read more

Info Session MBI Life Sciences & Health Academy

Read more

Biotech & Healthcare Conference - New York, US

Read more

Bio€quity Europe 2018

Read more

flanders.bio - Janssen Pharma Partner Day 2018: Innovate – Connect – Collaborate!

Read more

Best practices in Aseptic Processing Challenges, Solutions and site visits

Read more

Mithra Announces Completion of Recruitment in Donesta® Phase II Study

Read more

Laborama 2018

Read more

More stringent application of EU rules, affecting eligibility for grants & subsidies

Read more

Biocartis successfully raises EUR 80 million in an equity placement

Read more

Mithra Confirms Conversion of Subscription Rights

Read more

argenx reports positive topline results from Phase 2 proof-of-concept trial of ARGX-113 (efgartigimod) in generalized myasthenia gravis

Read more

European funding in Health workshop – looking for your idea!

Read more

Info session on the application of EU rules, affecting eligibility for grants & subsidies

Read more

MDxHealth Announces Lowering of 2017 Guidance

Read more

Acacia Pharma announces its intention to launch an initial global offering and to list its shares on Euronext Brussels

Read more

Imec.istart is ranked fourth in UBI Global’s University Business Accelerator ranking

Read more

Disclosure of a transparency notification

Read more

Previously announced tender offers by Sanofi to acquire Ablynx will commence on april 4, 2018

Read more

MDxHealth Shareholder Transparency Declaration

Read more

ThromboGenics Reports Initial Data from its Clinical Study evaluating THR-317, an anti-PlGF, for the Treatment of Diabetic Macular Edema (DME)

Read more

Grünenthal en KU Leuven bundelen de krachten om een nieuwe niet-opioïde pijnstiller te ontwikkelen

Read more

Promethera Biosciences Raised Additional EUR 9.3 Million to Advance a Broad Product Pipeline in Severe Liver Diseases

Read more

Biocartis: Results of the annual shareholders' meeting held on 11 May 2018

Read more

Biocartis: Two Performance Studies on Idylla(TM) MSI Biomarkers Selected for Publication at ASCO Conference

Read more

MDxHealth (R): Presentation of New Data on MDxHealth's Prostate and Bladder Cancer Products at AUA 2018 Annual Meeting

Read more

Mithra launches capital increase by means of a private placement via an accelerated bookbuild offering

Read more

argenx receives second preclinical milestone payment under its development agreement with AbbVie

Read more

GROWTH

Read more

NEW EARLY PHASE CLINICAL TRIALS PARADIGM - 6TH BIOPHARM DAY SEMINAR

Read more

Open Innovation Day with Boston Scientific

Read more

MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner

Read more

argenx reports positive topline results from Phase 2 proof-of-concept trial of efgartigimod in primary immune thrombocytopenia

Read more

Qarad nominated twice for TOPRA Awards

Read more

Shareholder Transparency Declaration MDxHealth

Read more

Mithra signs exclusive license and supply agreement with Adcock Ingram for commercialization of Estelle® in Southern Africa

Read more

argenx announces new cusatuzumab (ARGX-110) AML data in abstracts

Read more

Global Investor Forum: Leadership and Venture Growth

Read more

PwC enters into strategic partnership with flanders.bio

Read more

BioTrinity 2019

Read more

ChinaBio Partnering Forum 2019

Read more

Promethera Biosciences Announces Investment by ITOCHU Corporation and a Broad Strategic Collaboration to Access the Asian Markets

Read more

eTheRNA immunotherapies to present at Biotech Showcase and MyBioGate China Focus in San Francisco

Read more

argenx to Present at 37th Annual J.P. Morgan Healthcare Conference

Read more

Mithra Announces Attendance at the 37th Annual J.P. Morgan Healthcare Conference

Read more

MDxHealth (R): MDxHealth Provides Business Update

Read more

Start2Pharma: Basis GMP introductie

Read more

argenx announces closing of exclusive global collaboration and license agreement for cusatuzumab (ARGX-110) with Janssen

Read more

Mithra announces 2019 financial calendar

Read more

Biocartis successfully raises EUR 55.50 million

Read more

Information on the total number of voting rights and shares

Read more

Sequana Medical announces the Coverage of the Base Offering of Its Initial Public Offering on Euronext Brussels

Read more

Daily Newsflash - 14/02/2019

Read more

Healthy Ideas, Healthy Returns

Read more

Bone Therapeutics Notice of Full Year 2018 Results

Read more

Daily Newsflash - 28/02/2019

Read more

eTheRNA immunotherapies completes patient enrolment for Phase Ib-study in adjuvant melanoma

Read more

Mithra Signs License and Supply Agreement for Commercialization of Tibelia® in Chile

Read more

Biotechnology will take over Europe in September!

Read more

Oxurion NV Business Update - FY 2018

Read more

Genomics Application Platform – Imec.icon results presentation

Read more

Advanced & breakthrough therapies: from idea to patient

Read more

Microbiome & Probiotics Series: Europe

Read more

Biocartis Group NV: Biocartis Announces Global Collaboration with Covance

Read more

Vlaanderen investeert in gepersonaliseerde geneeskunde

Read more

Amerikaans ziekenhuis stelt genetische diagnose via artificiële intelligentie

Read more

FAIR Data Stewardship – digital data scholarship for wetlab scientists

Read more

flanders.health

Read more

Bootcamp in Rare Diseases

Read more

5 Flemish universities reveal innovative state-of-the-art biotech research at knowledge for growth 2019

Read more

Terrific year for Belgian biotech companies

Read more

Preventing cell death as novel therapeutic strategy for rheumatoid arthritis

Read more

Brain imaging AI leader icometrix raises $18 million in new funding

Read more

Sequana Medical announces presentation of positive DSR clinical proof-of-concept data demonstrating potential in volume overload due to heart failure

Read more

Health Tech Platforms: Bringing Innovation to Market

Read more

Bart Van Acker (Quality by Design) verkozen tot Jonge Vlaamse Ondernemer

Read more

VIB scientist Wout Boerjan elected as EMBO Member

Read more

flanders.bio is an independent life sciences cluster organisation based in Flanders, Belgium

Read more

Single-Use Event 2019: Challenges and opportunities in bioprocessing and biopharma

Read more

Jo Bury, VIB selected as member of the EIC Pilot Advisory Board

Read more

flanders.bio is an independent member-driven life sciences cluster organisation in Flanders (Belgium - EU)

Read more

FDA approves new cancer drug associated with KU Leuven discovery

Read more

Gilead and Galapagos enter into transformative research and development collaboration

Read more

Women Startup Challenge Europe HealthTech

Read more

Helis Academy GMP Cursus Niveau I

Read more

flanders.bio provides you with insights in the vibrant life sciences sector

Read more

Biocartis present at investor event VFB Happening this Saturday 25 March, Antwerp, BE

Read more

MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence

Read more

BioBase4SME Natural Fibertastic Workshop aims to encourage SMEs to apply for fully funded Bio-Innovation Coupons for fibre application testing

Read more

Novosanis receives Interreg CrossCare grant for its Colli-Pee™ device

Read more

MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Read more

Flanders Vaccine: A catalyst for public-private partnerships in vaccine related research and business

Read more

Scientists expose protein responsible for allergic diseases

Read more

Basisstatistiek voor onderzoekers - POSTACADEMISCHE OPLEIDING

Read more

Symposium on Sepsis

Read more

Data Transparency in Pharma R&D - Update on Policy 70 and first practical experiences

Read more

Infosessie Financiële steun voor innovatieve ondernemers

Read more

2017 IIBN Forum - Biotechnology: from Innovation to Industrial Production

Read more

Hospital 3D printing conference - Save the date

Read more

VIBes in Biosciences - International Symposium for PhD students in Life Sciences

Read more

Next-Generation Antibodies and Protein Analysis (2nd Edition) - A VIB TOOLS & TECHNOLOGIES CONFERENCE

Read more

Galapagos announces capital increase

Read more

Metastatic breast cancers: Characterising the profile of metastases for improved treatment

Read more

Galapagos announces new Phase 2 Proof-of-Concept study with filgotinib in cutaneous lupus erythematosus

Read more

Flanders @ BIOJapan 2017: Flemish Life Sciences & Biotech Week

Read more

Biocartis Group NV: Biocartis Q1 2017 Business Update

Read more

BioTrinity 2017 - Europe's Leading Biopartnering and Investment Conference

Read more

TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week

Read more

MDxHealth Trading Update: January to April 2017

Read more

FDA grants Fast Track Designation for Celyad’s ischemic heart failure therapy, C-Cure®

Read more

Mithra to Initiate PK Study for Estelle®

Read more

ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men

Read more

BioVox stelt white paper over kankerimmunotherapie voor: zal het kanker genezen?

Read more

Mithra & Gynial sign commercialization agreement for MyringTM in Austria

Read more

Mithra Receives GMP Approval for Myring™ Production

Read more

Bone Therapeutics strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors

Read more

Towards the Future: Synergizing Efforts for the Next Generation of Cell Therapeutics

Read more

International Course: Principles of Biosafety

Read more

Flanders @ BIO-Europe 2017

Read more

ThromboGenics to Present the Industry Pipeline of DME Treatments

Read more

Bone Therapeutics completes patient recruitment for pivotal interim analysis of Phase III Osteonecrosis trial with PREOB®

Read more

Mithra Receives Orphan Drug Designation from EMA for E4 in Neonatal Encephalopathy

Read more

QbD voegt QbD Software toe aan 360°-service in kwaliteitsmanagement

Read more

Quality - is it fit for the future?

Read more

Ablynx to present additional data for its anti-IL-6R nanobody, vobarilizumab, at the annual European Congress of Rheumatology

Read more

argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas

Read more

European Business Development Conference

Read more

Swissmedic has accepted for review the file on Cx601 for the treatment of Crohn's disease patients

Read more

Mithra Completes Recruitment for Additional Estelle® Safety Study

Read more

Mithra Launches a Capital Increase by Means of a Private Placement via an Accelerated Bookbuild Offering

Read more

Mithra Successfully Raises €26.1 Million

Read more

TiGenix to present at the 7th TERMIS-EU Conference in Davos, Switzerland

Read more

Advanced Materials for Biomedical Applications conference

Read more

MDxHealth Launches AssureMDx for Bladder Cancer Liquid Biopsy Test

Read more

The annual CRIG industrial partnering event

Read more

Ablynx proposes appointment of Mrs. Hilde Windels as a new independent director

Read more

TiGenix: Transparency Information

Read more

ConfirmMDx Featured in OncologyLive Magazine

Read more

MDxHealth to Participate in Canaccord Genuity Growth Conference

Read more

iTeos Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference

Read more

Mithra: Recruitment Completed in Estelle® Population PK Substudy

Read more

Versterk ons team! flanders.bio zoekt een communicatie-medewerker

Read more

MDxHealth Notice of January-June 2017 Financial Results

Read more

Mithra Announces First Subject Completes Estelle® Phase III Study

Read more

SuperBIO close to reaching its goal of developing 30 cross-border, cross-sectorial value chains in the biobased economy

Read more

Bone Therapeutics appoints Jean-Luc Vandebroek as Chief Financial Officer

Read more

Mindbytes expands to North America to develop next generation serious medical games driven by artificial intelligence

Read more

Biocartis Group NV: Idylla(TM) Respiratory (IFV-RSV) Panel receives 510(k) clearance by US FDA

Read more

Immunic Therapeutics Adds New Investors and Completes Series A Financing Round of Total EUR 31.7 Million

Read more

OPINNO educational module: Get to know the life sciences industry and its various job opportunities

Read more

Ablynx Announces Warrant Exercise

Read more

Mithra announces 2017 half year results

Read more

Life sciences meets micro-nanoelectronics: zooming in on MEDICAL DEVICES

Read more

Imec.istart verwelkomt nieuwe start-ups

Read more

Ablynx - Publication in accordance with art.14 of the Belgian Law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy law")

Read more

Ablynx prices $200 million Initial Public Offering in the United States

Read more

Suspension of trading in Ablynx shares on Euronext Brussels

Read more

Ablynx announces full exercise of underwriters' option to purchase additional shares and end of stabilization period

Read more

Ablynx closes $200 Million Initial Public Offering in the United States

Read more

Mithra Completes Recruitment for Estelle® Phase III Study in US and Canada

Read more

Ablynx closes on underwriters' option to purchase $30 million of additional shares in the U.S. initial public offering

Read more

MDxHealth Nine Month Trading Update

Read more

Ablynx - Publication in accordance with §14 of the Belgian law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy" law)

Read more

iTeos Therapeutics to Present New Data at Upcoming 2017 SITC Annual Meeting

Read more

MDxhealth teams up with Pharmaceutical Company Ferrer for distribution of its Prostate Cancer test SelectMDx in Spain

Read more

Ablynx - Results from the Phase III Hercules Study of Caplacizumab for the treatment of acquired TTP selected for presentation in the late-breaking abstracts session at the 2017 ASH annual meeting

Read more

JPMorgan Chase & Co notifies 3.12% shareholding in TiGenix

Read more

Structural Dynamics in Cellular Communication (2nd edition)

Read more

Mithra Finalizes Estelle® Contract with Brazilian Women’s Health Leader Libbs

Read more

argenx announces launch of proposed public offering in the United States

Read more

Make your perfect pitch for Life Sciences investors

Read more

argenx announces closing of U.S. public offering for gross proceeds of approximately $266 million

Read more

Life Sciences & Healthcare Inhouse Day

Read more

ONTOFORCE wint de TechTour Venture Contest 2017 in de categorie HealthTech

Read more

Mithra and Adamed Sign Commercialization Agreement for MyringTM in the Czech Republic

Read more

Imec’s SWEET study Collects World’s Largest Dataset on Stress Detection

Read more

CMAST nominated for Trends Gazellen 2018 (East Flanders), for the 3rd time in a row!

Read more

MDxHealth financial results

Read more

Mithra presents positive hemostasis results at ISGE conference

Read more

VIB Plant-derived volatiles may serve as future antifungals

Read more

Flanders @ BIOJapan 2018: Flemish Life Sciences & Biotech Week

Read more

Biocartis Selected for Oral Presentation at Cancer Research Meeting

Read more

Mithra Announces Completion of Estelle® Cycles Required in Phase III Contraception Studies

Read more

DuPont and Inbiose Celebrate EU Regulatory Approval of Their First Human Milk Oligosaccharide Ingredient for Infant Formula

Read more

MDxHealth Shareholder Transparency Declaration

Read more

Biocartis Group NV: Oproeping tot de Gewone Algemene Aandeelhoudersvergadering

Read more

Bone Therapeutics Notice of Full Year 2017 Results

Read more

Galapagos creates new warrant plan

Read more

MDxHealth Provides First Quarter 2018 Business Update

Read more

MDxHealth releases 2017 Annual Report

Read more

Mithra Announces Last Subject Visit in Estelle® Phase III Study in EU/Russia and Completion of Endometrial Substudy

Read more

Do you have to become officially a BIOBANK under the new Belgian law?

Read more

CMAST presents new website and look & feel at Europe’s 2nd largest life sciences conference

Read more

GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS

Read more

Accelerating your healthcare start-up – boot camp selection day

Read more

Gilead and Galapagos announce results with filgotinib in the phase 2 equator study in psoriatic arthritis and progression into phase 3 for the selection study in ulcerative colitis

Read more

Mithra: information on the total number of voting rights

Read more

Bone Therapeutics: Information on the total number of voting rights and shares

Read more

TiGenix announces a change in its Board of Directors and its Management Team

Read more

Antwerps bedrijf QbD nu ook aanwezig in Zuid-Amerika

Read more

Biocartis Group NV: Study Reviewing 2,500 Performed Idylla(TM) Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods

Read more

Biogazelle appoints Armin Winands as new CEO

Read more

MDxHealth: SelectMDx Study Demonstrates Cost-effectiveness in US Healthcare System

Read more

ISTA Congress London

Read more

Mithra announces positive top-line results of estelle® phase III oral contraceptive study in eu/russia

Read more

MDxHealth (R): MDxHealth Shareholder Transparency Declaration

Read more

MDxHealth (R) : MDxHealth Notice of Interim Results 2018

Read more

Helis Academy (Interreg)

Read more

Janssen verdiept samenwerking met Universiteit Gent en Universitair Ziekenhuis Gent in ambitieus innovatiecharter

Read more

Bioprocessing in the future: Single-Use and Continuous

Read more

Ardena expands nanomedicine capabilities

Read more

Gilead and Galapagos announce filgotinib meets primary and all key secondary endpoints in first phase 3 study in rheumatoid arthritis

Read more

Genesis 2018

Read more

State of the Union 2019

Read more

Amerikaanse immunoloog Dr. James Allison wint Nobelprijs

Read more

The right funding at the right time: how to make the right call?

Read more

Biocartis Group NV: Studies on Idylla(TM) MSI and RAS liquid biopsy tests to be presented at ESMO congress

Read more

Dutch Life Sciences conference

Read more

Bone Therapeutics announces conclusions from interim analysis of Phase III PREOB study in hip osteonecrosis

Read more

MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices

Read more

Convert Pharmaceuticals appoints Mariola Söhngen as new CEO

Read more

Type 2 Immunity in Homeostasis and Disease

Read more

Revolutionizing Next-Generation Sequencing (3rd edition)

Read more

Mithra Announces the Completion of its Lead Clinical Phase III Programme for Estelle®

Read more

Mithra signs exclusive license and supply agreement for vaginal contraceptive ring in Australia and New Zealand

Read more

Mithra Announces Positive Results of Ovarian Function Sub-Study which Strengthens Estelle® Contraceptive Efficacy Profile

Read more

Confo Therapeutics Appoints Frank Landolt as its Chief Counsel Legal & Intellectual Property

Read more

MyCartis to engage in point-of-need testing with the ANTELOPE Dx platform technology

Read more

Domus Medica and VITO collaborate on preventive health care

Read more

SCK•CEN Space summer school

Read more

Confo Therapeutics sluit exclusieve, wereldwijde licentie met VIB voor gebruik van nieuwe, baanbrekende technologie

Read more

Sands Capital reports 5.7% holding in Galapagos

Read more

A new generation of Genetically Modified (GM) vaccines: How to overcome the hurdles from bench to practice?

Read more

EuroChem and Aphea.Bio launch R&D collaboration

Read more

Start2pharma: technical writing of wi’s

Read more

Mithra Strengthens Management Team With Key Appointments

Read more

Inari Broadens Research Footprint With Expansion to Belgian Life Sciences Hub

Read more

Mithra Signs Exclusive License and Supply Agreement for Commercialization of Myring™ in the Middle East

Read more

Talent accelerator programme for biobusiness

Read more

Mithra Successfully Produces its First Commercial Batch of Myring™ for Europe

Read more

Galapagos: Firmly on our way to becoming a fully integrated biopharma company

Read more

BioTech meets Digital

Read more

Confo Therapeutics stelt wetenschappelijke adviesraad aan en versnelt de ontwikkeling van zijn gepatenteerd platform voor de ontdekking van nieuwe geneesmiddelen

Read more

Naar een coöperatief model voor de Life Sciences: Antleron wijst de weg

Read more

Daily Newsflash - 11/03/2019

Read more

Biocartis Group NV: Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies

Read more

KU Leuven | UZ Leuven - Lieven Scheire theaterlezing

Read more

Daily Newsflash - 14/03/2019

Read more

Mithra Demonstrates Further Estetrol’s Unique Profile at the Annual Meeting of the Endocrine Society

Read more

Mithra receives Orphan Drug Designation from FDA for E4 in neonatal encephalopathy treatment

Read more

Mithra wins essenscia Innovation Award 2019 for its new generation contraceptive pill, Estelle®

Read more

Oxurion NV announces full enrollment of its Phase 2 trial for treatment of DME, ahead of schedule

Read more

Daily Newsflash - 10/04/2019

Read more

VIB: Permit for CRISPR maize field trial that aims to measure climate stress

Read more

Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients

Read more

Workshop: Blockchain in Clinical Trials

Read more

Mithra Signs License and Supply Agreement for Commercialization of Myring™ in Latin and South America

Read more

Galapagos reports on historic first quarter 2019

Read more

Fluidda and Materialise announce partnership to develop personalized solutions for lung patients

Read more

Do ‘microglia’ hold the key to stop Alzheimer’s disease?

Read more

New social, ethical & economic impact studies and activities developed by Sanquin

Read more

Confo Therapeutics raises €30 million in Series A financing

Read more

Detailed brain map uncovers hidden immune cells that may be involved in neurodegenerative disorders

Read more

From discovery to submission and beyond - get to know the full Pharmalex portfolio

Read more

Idylla(TM) MSI Performance Study Selected for Publication at ASCO Conference

Read more

OCTIMET Oncology announces the appointment of Shelley Margetson as CEO

Read more

Out of the Lab & Into the Newsroom: Media 101

Read more

Mithra Signs LSA for Commercialization of Myring™ in Germany, the biggest market in Europe

Read more

Science for Health 2019

Read more

Biotech leaders conference

Read more

Europe Biobank Week

Read more

Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients

Read more

Winnaar van de Dr. Paul Janssen Award voor Biomedisch Onderzoek bekend

Read more

VIB-KU Leuven: Duvel Moortgat opens scientific pilot brewery and presents BSSH Awards to Sir Paul Nurse, 2001 Nobel Laureate

Read more

VIB: A single gut enterotype linked to both inflammatory bowel disease and depression

Read more

Confo Therapeutics ontvangt €1,7 miljoen subsidie van VLAIO.

Read more

Flanders @ Bio-Europe 2019

Read more

Biotechdag 2019: Microben onzichtbaar & onmisbaar

Read more

Nordic Life Science Days 2019

Read more

Development of a new leishmaniasis drug wins EU funding

Read more

PHD2 targeting overcomes breast cancer cell death upon glucose starvation

Read more

VIB and DNAlytics team up to develop non-invasive Colorectal Cancer screening test

Read more

Belgian PCR interpretation software company UgenTec partners with multiplex molecular diagnostics innovator PathoFinder

Read more

Biocartis Group NV: Biocartis announces publication of 2016 Annual Report

Read more

argenx announces first patient dosed in Phase II proof-of-concept study of ARGX-113 for the treatment of primary immune thrombocytopenia

Read more

Biocartis Group NV: Biocartis establishes US subsidiary and appoints US General Manager

Read more

Academia-Industry Connect Meeting: Knowledge Valorisation: Matching science and market needs

Read more

Esperite N.V. with CryoSave contributes to treating a 9 year old child with thalassema major in Switzerland

Read more

argenx announces results of Annual General Meeting 2017

Read more

Celyad initiates second dose escalation in THINK trial in first US patient

Read more

Ex-Janssen topman Dr. Ajit S. Shetty in de raad van bestuur van Actinium Pharmaceuticals

Read more

argenx announces launch of proposed initial public offering in the United States

Read more

argenx announces size of initial public offering in the United States increased to 5 million ADSs

Read more

Helena Biosciences to develop automated blood test for chronic liver disease based on VIB and Ghent University research

Read more

Overnight skin care

Read more

500 vacancies in the Flemish biotech sector

Read more

Celyad Announces First Quarter 2017 Business Update

Read more

argenx announces full exercise of underwriters' option to purchase additional ADSs

Read more

Biocartis Group NV: Biocartis launches CE-marked IVD NRAS test for colorectal cancer

Read more

argenx announces closing of NASDAQ IPO

Read more

MDxHealth: Annual General Shareholders' Meeting

Read more

Genohm at “Les Rencontres Toulousaines du Club 3CR”

Read more

Ablynx appoints Markus Ewert as Chief Business Officer

Read more

Biocartis Group NV: Disclosure of a transparency notification

Read more

TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn’s Disease and Ulcerative Colitis

Read more

pi partners up to raise awareness on early-onset dementia

Read more

MDxHealth Presents Three SelectMDx Studies at 5th Global Congress on Prostate Cancer

Read more

SelectMDx to be Distributed Across Middle East by IPS Genomix

Read more

Industrial automation companies from Baden-Württemberg looking for collaborations

Read more

Seminarie: Waarom Vlaanderen nood heeft aan een opleidingscentrum voor de farmasector

Read more

argenx to Present at Wedbush PacGrow Healthcare Conference

Read more

GLPG1690 halts disease progression in IPF patients in FLORA Phase 2a trial

Read more

argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results

Read more

argenx reports second quarter business update and half-year 2017 financial results

Read more

OLVZ Aalst User Experience Day

Read more

SelectMDx Outperforms PCA3 Stratifying Men for mpMRI

Read more

Flanders @ Naturejobs Career Expo - Düsseldorf

Read more

Flanders @ BIO International Convention 2018

Read more

Advipro (Lille+Willebroek) scoort met Europese scoop voor farmasector en investeert in uniek trainingscenter met operationele cleanroom

Read more

Bone Therapeutics announces all patients meet primary endpoint in ALLOB® Phase I/IIA delayed-union study interim analysis

Read more

R-Biopharm AG & UgenTec partner to develop software for automated PCR analysis

Read more

Camel-IDS appoints Ruth Devenyns as Chief Executive Officer

Read more

MDxHealth Opens New Service and Research Laboratory in The Netherlands

Read more

TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting

Read more

Seminar: How Real World Data will change your clinical development to the better

Read more

ONTOFORCE wins the EIT Venture Award 2017

Read more

flanders.bio launches new website for its flagship event knowledge for growth

Read more

argenx reports third quarter 2017 financial results and provides business update

Read more

International recognition for Dirk Inzé

Read more

Consistent safety findings and durable activity with filgotinib treatment of rheumatoid arthritis patients up to week 84 in DARWIN 3 study

Read more

Imec Designs and Fabricates World-First Miniature Neural Probe for Simultaneous Recording of Multiple Brain Regions at Neuronal Resolution

Read more

Biocartis Group NV: BIOCARTIS Q3 2017 BUSINESS UPDATE

Read more

Mithra Announces Positive Outcome of Myring™ Commercial Batch Bioequivalence Study

Read more

Publication of a Transparency Notification Received by Mithra Pharmaceuticals sa/nv

Read more

Medical Biotechnology

Read more

Metabolism in Cancer and Stromal Cells (2nd edition)

Read more

New start-up Aelin Therapeutics secures 27M Euros to pioneer the development of a novel drug modality

Read more

BioFIT 2018

Read more

reMYND enters into license agreement with Novo Nordisk

Read more

argenx raises approximately $231 million in gross proceeds in an upsized U.S. public offering

Read more

iTeos Therapeutics Regains Worldwide Rights to Clinical-Stage IDO1 Inhibitor

Read more

Business Developers Program for Life Sciences - Course

Read more

Galapagos - Positive topline results with GLPG1972 in osteoarthritis patients

Read more

Will 2018 be the year of biotech M&A? - An analysis by KBC Securities

Read more

BARC and Biogazelle announce collaboration for advanced genetic testing in clinical trials

Read more

MDxHealth (R): Develops Blood Test to Guide Precision-Treatment of Castration-Resistant Prostate Cancer Patients

Read more

ONTOFORCE haalt 4,3 miljoen euro op in een Series A financiering

Read more

SLAS Europe 2018

Read more

flanders.bio announces upcoming changes in its staff

Read more

Mithra announces very promising hemostasis results for Estelle®

Read more

Connect met Digital Health Start-ups

Read more

MEDTECH MEETUP 2019

Read more

European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects

Read more

argenx reports fourth quarter business update and full year 2017 financial results

Read more

Biocartis announces 2017 results and 2018 outlook

Read more

Argenx to Present at Cowen & Company 38th Annual Health Care Conference

Read more

Internationalisatie voor Medtech & Biotech Start-Ups

Read more

CTLS2018@VIB

Read more

Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

Read more

MITHRA and ALVOGEN sign LSA for vaginal contraception ring in Russia

Read more

MDxHealth (R): SelectMDx Liquid Biopsy Test for Prostate Cancer included in the 2018 European Association Urology Guidelines

Read more

VLAIO kent QbD subsidie toe voor innovatie in celtherapie procesontwikkeling

Read more

Onderzoekers ontdekken hoe twee genen samen leukemie aanwakkeren

Read more

flanders.bio - Roche Diagnostics Partner Day 2018: ’Towards high-quality Cell Therapy’

Read more

argenx announces Annual General Meeting of Shareholders on May 8, 2018

Read more

Life sciences & health, alle kennis onder één dak

Read more

Mithra applies for additional estelle® patent based on positive hemostasis data

Read more

UgenTec: announcing our $ 9.3 million Series A funding

Read more

argenx to present complete data from the Phase 2 clinical trial of efgartigimod (ARGX-113) in myasthenia gravis at the American Academy of Neurology Annual Meeting

Read more

IEX Beleggersdag

Read more

Biocartis Group NV: Disclosure of outstanding voting securities

Read more

Promethera Biosciences Announces Updates to its Board of Directors

Read more

Icometrix: analyse van hersenscans kan leiden tot een verbeterde diagnose van dementie

Read more

Flanders @ BIO-Europe 2018

Read more

MDxHealth Announces Positive Clinical Updates for ConfirmMDx

Read more

Ablynx announces Warrant Exercise

Read more

Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients

Read more

Bone Therapeutics Information on the total number of voting rights and shares

Read more

Ardena acquires Syntagon and strengthens API offering

Read more

Israeli endoscopy startup 3NT Medical announces initial closing of $15M to include key strategic investor

Read more

argenx reports first quarter 2018 financial results and provides business update

Read more

ThromboGenics Business Update - Q1 2018

Read more

Bone Therapeutics: preliminary documents for the Annual Ordinary and the Extraordinary General Shareholder Meeting

Read more

flanders.bio Ghent becomes biotechnology capital of europe

Read more

Sanofi and Ablynx announce the successful results of the initial tender offer period for ablynx and commencement of squeeze-out tender period

Read more

Mithra announces injectable contract with Midas Pharma

Read more

ProDigest: PROMISE

Read more

Imec Presents Novel Organ-on-Chip Platform for Drug Screening

Read more

The first annual Benelux Precision Medicine Forum

Read more

CMAST: New partnership launched to facilitate the development of new drugs for children across Europe

Read more

Mithra successfully raises eur 77.5 million

Read more

België opnieuw met topdelegatie op 25e editie BIO International Convention

Read more

MDxHealth launch agreement with Philips for prognostic prostate cancer biomarker

Read more

argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris

Read more

MDxHealth's SelectMDx Test Successfully Stratifies Men

Read more

Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid in respect of TiGenix

Read more

ELIXIR Innovation and SME Forum

Read more

Microbiome pioneer S-Biomedic secures investment and collaboration with global skin care company beiersdorf

Read more

De oprichting van “Flow Alliance” geeft een boost aan de wereldwijde beschikbaarheid van kunststof microfluïdische producten

Read more

argenx to host conference call & webcast to report second quarter business update and half year 2018 financial results on August 2, 2018

Read more

Mithra announces belux agreement with ceres pharma worth over eur 40 million

Read more

Biocartis Group NV: Study Abstract on Performance of Idylla(TM) RAS tests Selected for Oral Presentation at 70th AACC Annual Scientific Meeting in Chicago, IL (US)

Read more

Takeda rondt overname van TiGenix af na het verstrijken van de Uitkoopperiode

Read more

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee

Read more

Excited About Your Story: Tell it like a TED Pro

Read more

SelectMDx Cost-effective in Four European Countries

Read more

Bio Business Winter Retreat - Enhance your career in BioBusiness

Read more

Biocartis Creates New Warrant Plan

Read more

OPINNO BioBizz Café Brussels

Read more

OPINNO BioBizz Café Leuven

Read more

OPINNO educational module Antwerp: Get to know the life sciences industry and its various job opportunities

Read more

argenx raises approximately $300.6 million in gross proceeds in a U.S. public offering

Read more

argenx announces closing of U.S. public offering for gross proceeds of approximately $300.6 million

Read more

Mithra Signs Exclusive License And Supply Agreement For The Commercialization Of Myring™ In Chile With Laboratorio Pasteur

Read more

Oxurion NV to Present at the Upcoming Ophthalmology Innovation Summit and Provide a Clinical Update at the American Academy of Ophthalmology 2018 Annual Meeting

Read more

Het succes van de Vlaamse biotechsector duwt de groei van gespecialiseerde toeleveranciers spectaculair de hoogte in.

Read more

ProDigest has been nominated for the Deloitte Technology Fast 50

Read more

Emerging Applications of Microbes

Read more

The Brain Mosaic: Cellular heterogeneity in the CNS (2nd edition)

Read more

Imec: een contactlens die ziektes opspoort en medicatie toedient?

Read more

Flanders @ BIO International Convention 2019

Read more

JLABS @ BE Info Session (webinar)

Read more

argenx enters exclusive global collaboration and license agreement with Cilag GmbH International, an affiliate of Janssen, for cusatuzumab (ARGX-110)

Read more

Oxurion NV to Present at 2019 Biotech ShowcaseTM Conference

Read more

BioPharm America™ 2018

Read more

BIO Asia International Conference

Read more

Mithra announces complex therapeutics update

Read more

How to scale and go-to-market successfully

Read more

AgroSavfe Announces Adrian Percy As New Independent Board Member

Read more

Daily Newsflash - 11/01/2019

Read more

Daily newsflash - 14/01/2019

Read more

Daily Newsflash - 15/01/2019

Read more

Daily Newsflash - 18/01/2019

Read more

Bone Therapeutics announces 2019 business outlook and reports year-end 2018 cash position

Read more

Preservation of micro-organisms: a practical approach

Read more

Daily Newsflash - 24/01/2019

Read more

Daily Newsflash - 11/02/2019

Read more

Daily Newsflash - 12/02/2019

Read more

Daily Newsflash - 13/02/2019

Read more

Daily Newsflash - 15/02/2019

Read more

Daily Newsflash - 18/02/2019

Read more

Microbiome pioneer S-Biomedic completes series A round with DSM Venturing

Read more

Janssen Pharmaceutica investeert 21 miljoen euro in “productie van de toekomst” op de Janssen Campus in Beerse

Read more

Daily Newsflash - 19/02/2019

Read more

Daily Newsflash - 26/02/2019

Read more

Biocartis Group NV: Biocartis announces CE-IVD marking of its Idylla(TM) MSI Test

Read more

Celyad Appoints Anne Moore as Vice President Corporate Strategy

Read more

Daily Newsflash - 12/03/2019

Read more

BIOMED PARTNERING DRINK

Read more

argenx to receive first clinical milestone payment for product candidate developed under option agreement with AbbVie

Read more

Daily Newsflash - 15/03/2019

Read more

Daily Newsflash - 18/03/2019

Read more

Daily Newsflash - 19/03/2019

Read more

Sound of Science

Read more

5 VIB researchers receive an exceptional ERC Advanced grant

Read more

Publication of the annual report and invitation to the annual shareholders' meeting

Read more

Novosanis enters into distribution deal with Fujirebio

Read more

Galapagos creates new warrant plans

Read more

flanders.bio life sciences news - 11/04/2019

Read more

Daily Newsflash - 16/04/2019

Read more

MouSensor is now Yesse Technologies

Read more

Daily Newsflash - 18/04/2019

Read more

QbD Jobday

Read more

Mindbytes bvba publishes first peer-reviewed manuscript on its serestm methodological framework and demonstrates proof-of-concept

Read more

eTheRNA immunotherapies opens new research base in Ghent

Read more

Daily Newsflash - 14/05/2019

Read more

Daily Newsflash - 16/05/2019

Read more

Daily Newsflash - 20/05/2019

Read more

argenx announces pipeline expansion and “argenx 2021” vision to build integrated immunology company at 2019 R&D Day

Read more

ViroVet and Pirbright join forces to develop African swine fever antivirals

Read more

Daily Newsflash - 29/05/2019

Read more

eTheRNA: Linking clinical cure of metastatic melanoma with immune responses in the TriMix DC-MEL IPI study.

Read more

eTheRNA: Safety and immune stimulation data from an intranodal delivery of TriMix mRNA, in the adjuvant melanoma study E011-MEL

Read more

Life Sciences Jobs

Read more

Daily Newsflash - 11/06/2019

Read more

Daily Newsflash - 12/06/2019

Read more

Daily Newsflash - 13/06/2019

Read more

Daily Newsflash - 17/06/2019

Read more

Daily Newsflash - 18/06/2019

Read more

Gene technology today: a practical approach

Read more

Single-Use Event 2018: Bioprocessing in the future: Single Use and Continuous

Read more

De onstuitbare opmars van biotechnologie

Read more

Daily Newsflash - 01/07/2019

Read more

Confo Therapeutics en DyNAbind bundelen krachten in de zoektocht naar nieuwe geneesmiddelen

Read more

Daily Newsflash - 12/07/2019

Read more

BioPharm America™ 2019

Read more

BioFIT 2019

Read more

Novosanis signs an agreement to provide MDxHealth a customized urine collection device

Read more

Bootcamp in Entrepreneurial Innovation in Orphan Diseases

Read more

Nieuws van de dag - 26/04/2017

Read more

Aratana Therapeutics Provides Update on ENTYCE®

Read more

Nieuws van de dag - 27/04/2017

Read more

Galapagos presents pre-clinical data with selective ADAMTS-5 inhibitor GLPG1972 for osteoarthritis at OARSI

Read more

MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx

Read more

ABLYNX COMPLETES PATIENT RECRUITMENT IN ITS PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF aTTP

Read more

argenx reports first quarter 2017 financial results and provides business update

Read more

Nieuws van de dag- 4/05/2017

Read more

VIB: A new unexpected key player in melanoma development identified

Read more

Galapagos presents three posters on filgotinib in Crohn's disease at DDW® 2017

Read more

Bone Therapeutics Business Update for First Quarter 2017

Read more

ABLYNX REPORTS FINANCIAL RESULTS FOR THE FIRST THREE MONTHS OF 2017 AND A YEAR-TO-DATE BUSINESS UPDATE

Read more

ThromboGenics Business Update - Q1 2017

Read more

Ablynx to present at upcoming USA Investor Conferences

Read more

SLims by Genohm integrated with Pathomation’s PMA.core

Read more

Biocartis Group NV: Study demonstrating high performance of Idylla(TM) liquid biopsy RAS tests to be presented at ASCO Annual Meeting

Read more

argenx raises approximately $100 million gross proceeds with NASDAQ IPO

Read more

Nieuws van de dag- 19/05/2017

Read more

Researchers discover mechanism behind rapid smell source localization

Read more

ThromboGenics NV to present THR-317 Pre-clinical Research Findings

Read more

Cochlear acquires exclusive licence to Artificial Intelligence assistant

Read more

ESPERITE (ESP) has concluded new agreements with its note holders

Read more

Cell Death and Immunity in Disease: from molecules to translational medicine

Read more

Biocartis wins prestigious Galenus Prize with its Idylla(TM) NRAS-BRAF Mutation Test for colorectal cancer

Read more

TiGenix to present at the Jefferies 2017 Global Healthcare Conference in New York

Read more

Innovation for Health 2018

Read more

Mithra Signs Exclusive Agreement for Tibelia® in Canada

Read more

TiGenix announces final equity payment for cardiac platform acquisition

Read more

Biocartis launches CE-marked IVD test for lung cancer

Read more

TiGenix Launches Global Phase III Trial for Cx601

Read more

VITO sterk in ontwikkeling van dierproefvervangende testmethoden

Read more

Software as a Medical Device

Read more

Celyad reports promising early results at first dose level of the solid arm of the THINK trial

Read more

Researchers gain new insights into the formation of non-pathological amyloids

Read more

Europa, Vlaanderen, Provincie Oost-Vlaanderen en Stad Gent investeren samen 9,36 miljoen EURO in de Bio Base Europe Pilot Plant

Read more

Visionary seminar: 'Regenerative Medicine: Growing the Future'

Read more

Bone Therapeutics receives Intent to Grant Notice from European Patent Office for allogeneic bone cell therapy platform

Read more

Ablynx initiates a single and multiple dose phase I study of caplacizumab in healthy Japanese subjects

Read more

Estelle® Phase IIB results on well-being and body weight published in leading peer-reviewed journal

Read more

Daily Newsflash- 27/06/17

Read more

Mithra Signs Exclusive License and Supply Agreement with Fuji Pharma for Donesta® in Japan and Asean

Read more

Unchained Labs acquires Trinean

Read more

iTeos Therapeutics Appoints Mohamed Ragab, M.D. as Vice President, Corporate Development

Read more

eTheRNA immunotherapies advances In-Vivo mRNA Cancer Immunotherapy into first Oncology Clinical Studies

Read more

Bone Therapeutics Strengthens Board of Directors

Read more

27 Vlaamse bedrijven en onderzoeksinstellingen bundelen krachten in 3D-print project ‘Family of the Future’.

Read more

Galapagos: New Phase 2 study with filgotinib in non-infectious uveitis

Read more

Mithra Strengthens E4 Patent Position in Australian Market

Read more

Daily Newsflash- 10/07/2017

Read more

Biocartis Group NV: Biocartis' Idylla(TM) Instrument and Idylla(TM) Console exempt from US FDA 510(k) notification requirements

Read more

Kankersymposium 'Worden alle kankers behandelbaar? Van onderzoek tot hoop'

Read more

Celyad announces initiation of the SHRINK trial

Read more

MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion

Read more

MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group

Read more

Immunity for Health 2017

Read more

ELIXIR Innovation and SME Forum: Data-driven innovation in food, nutrition and the microbiome

Read more

Personalised nutrition for better health - targeting the microbiome

Read more

L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 0.6 million

Read more

Bone Therapeutics Notice of Half Year 2017 Results

Read more

Ablynx announces 2017 half year results and year-to-date business update

Read more

Celyad Reports First Half 2017 Financial Results and Operational Progress

Read more

Bone Therapeutics announces H1 results for 2017

Read more

Biocartis Group NV: Strong performance data of proprietary MSI Biomarkers for the Idylla(TM) MSI Test to be published at ESMO

Read more

Biocartis Group NV: Biocartis announces 2017 half-year results on 7 September 2017

Read more

MDxHealth Prepares for Growth with Executive Team Expansion

Read more

Biocartis announces H1 2017 results

Read more

ThromboGenics Business Update - H1 2017

Read more

PharmaFluidics appoints Fasha Mahjoor as independent director

Read more

flanders.bio's Life Sciences & Biotechcafé tijdens VIB-Biotechdag 2017

Read more

flanders.bio's General Assembly

Read more

2nd Symposium : « Introduction of the Next-Generation-sequencing technology in routine analysis in the Belgian healthcare »

Read more

ABL acquisition extends Ardena’s early-phase offering

Read more

pi life sciences consultancy launches Music For Life-campaign to lift the taboo on young dementia

Read more

Promethera Biosciences to Present at Several International Partnering and Scientific Conferences this Fall

Read more

argenx launches Phase II proof-of-concept clinical trial of ARGX-113 for the treatment of pemphigus vulgaris

Read more

TiGenix to participate and present at key investor and business development meetings

Read more

Pharmacokinetics in Drug Development - 2017

Read more

Ablynx announces positive topline results from the Phase III Hercules Study of Caplacizumab for the treatment of acquired TTP

Read more

Celyad reports a first complete response in a relapsed refractory AML patient in the THINK trial

Read more

flanders.bio joins forces with FIT to support the internationalisation of Flanders’ economy

Read more

Participation by Capricorn Venture Partners completes ViroVet’s series A funding

Read more

Capricorn Venture Partners stapt in kapitaal van ViroVet NV

Read more

Ablynx - Publication in accordance with art.14 of the Belgian law of 2/05/2017 regarding the publication of major shareholdings (the "transparancy law")

Read more

BIO-Europe Spring® 2018

Read more

Dinner with Chef Watson

Read more

Ablynx announces launch of proposed global offering

Read more

Bridging Preclinical and Clinical Development

Read more

Ablynx - Notice in Relation to the Convertible bonds due May 2020

Read more

Galapagos Q3: clinical success with GLPG1690 and MOR106 highlights strength of deep pipeline

Read more

Bio Base NWE project wins RegioStars Award 2017

Read more

MyCartis appoints Philippe Stas as CEO

Read more

MDxhealth Enters into Distribution Agreement with Unilabs for SelectMDx for Prostate Cancer

Read more

Mithra Announces Launch of Warrant Exercise Period

Read more

TiGenix strengthens European IP protection around lead development program Cx601

Read more

TiGenix announces partial conversion of bonds

Read more

Ablynx - Correction of Publication in accordance with §14 of the Belgian law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy" law)

Read more

Ablynx - Publication in accordance with §14 of the Belgian law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy" law) (1)

Read more

Navarra-Flanders Global Business Bridges

Read more

ThromboGenics Strengthens Leadership Team

Read more

Bone Therapeutics Business Update for Third Quarter 2017

Read more

Ionis Pharmaceuticals licenses novel antisense drug for the treatment of centronuclear myopathy to dynacure

Read more

argenx to Present at Upcoming Investor Conferences

Read more

Ablynx: publication regarding the publication of major shareholdings (the "transparancy law")

Read more

Personalised Medicine - van lab naar patiënt

Read more

De Clercq & Partners seminar 2017

Read more

Ablynx announces results for the first nine months of 2017 and a year-to-date business update

Read more

Mindbytes initiates oncology R&D program focused on patient empowerment and is selected as one of five finalists for Astellas Oncology C3 Prize®

Read more

Celyad Announces Third Quarter 2017 Business Update

Read more

Mithra Announces 36-month Shelf Life Extension for Tibelia®

Read more

Visionary seminar: 'Human Genome Editing: Challenges, New Technologies and Ethics'

Read more

Ablynx - Publication in accordance with §14 of the Belgian Law

Read more

Mithra Provides Update on Estelle® and Donesta® Studies

Read more

Mithra Announces Valorization of French Subsidiary

Read more

Ablynx to host webcast about Phase III Hercules Study

Read more

Ablynx reports additional clinically important benefits of Caplacizumab from its Phase III Hercules Study in acquired TTP

Read more

Daily Newsflash - 13/12/2017

Read more

Nordic Life Science Days 2018

Read more

BIO World Congress on Industrial Biotechnology

Read more

ChinaBio Partnering Forum 2018

Read more

Mithra Announces Injectables Agreement with GSP

Read more

IMPACT of the Bio Base Europe Pilot Plant in industrial biotechnology

Read more

Galapagos Transparency notification

Read more

TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform

Read more

Ablynx - notice in relation to waiver of lock-up restriction

Read more

Ablynx strongly believes unsolicited conditional proposal from Novo Nordisk fundamentally undervalues the company and its future prospects

Read more

TiGenix - Transparency Information

Read more

Bone Therapeutics provides business outlook and announces its financial calendar for 2018

Read more

Ablynx appoints dr. Robert Friesen as Chief Scientific Officer

Read more

new England biolabs® and Bluebee partner to deliver an end-to-end data analysis solution for Nebnext direct® target enrichment

Read more

Eerstesteenlegging UGent-VIB Onderzoeksgebouw FSVM II

Read more

Bone Therapeutics strengthens Board with the appointment of Jean Stéphenne as Chairman

Read more

Rousselot innovation days 2018

Read more

MDxHealth contract SelectMDx with Roman Hospital

Read more

Trapping multidrug-resistant bacteria in molecular glue

Read more

Pauwels Consulting is Trends Gazelle 2018 van de Provincie Vlaams-Brabant

Read more

Biocartis Establishes R&D Center in the US

Read more

Ablynx commences dosing in its Phase II Study of ALX-0171 in hospitalised Japanese infants with a RSV infection

Read more

European Business Development Conference 2018

Read more

Daily newsflash - 12/03/2018

Read more

Mithra and Mayne Pharma’s Vaginal Contraceptive Ring Accepted for Filing by FDA

Read more

TiGenix en Takeda kondigen aan dat Alofisel® (darvadstrocel) de goedkeuring krijgt voor de behandeling in Europa van complexe perianale fistels bij de ziekte van Crohn

Read more

Sound of science

Read more

Promethera Biosciences to Present New NASH Data at Two International Scientific and Partnering Conferences in April

Read more

argenx appoints Keith Woods as Chief Operating Officer

Read more

Mithra signs principle agreement for commercialization of Estelle® in canada

Read more

Galapagos announces ISABELA Phase 3 program in IPF

Read more

Mithra releases 2017 Annual Report and invitation to its Ordinary General Shareholders' Meeting

Read more

BIOSPAIN 2018

Read more

MDxHealth (R): SelectMDx Included in Dutch DRG Reimbursement System

Read more

argenx to present complete data from the Phase 2 proof-of-concept trial of efgartigimod (ARGX-113) in generalized myasthenia gravis at American Academy of Neurology (AAN) Annual Meeting

Read more

Bone Therapeutics Reports Full Year 2017 Results

Read more

Biocartis Q1 2018 business update

Read more

TiGenix: Publicatie van prospectus en memorie van antwoord voor het overnamebod van Takeda dat begint op 30 april 2018

Read more

Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018

Read more

Ablynx completes patient recruitment in the Phase IIb Respire Study of its inhaled anti-RSV Nanobody ALX-0171

Read more

Daily Newsflash - 30/04/2018

Read more

Agilent Technologies to Enhance Lab Informatics with Acquisition of Genohm

Read more

Advipro Job Tasting Day

Read more

Bone Therapeutics Business Update for First Quarter 2018

Read more

flanders.bio - NBN event: Standards for Biotech

Read more

VIB: Nieuwe genetische oorzaak van lupus ontdekt

Read more

Flanders.bio appoints new management team to step up its strategy

Read more

Diploid Leuvense software voor genoomanalyse wint prestigieuze prijs in de VS

Read more

ThromboGenics to present a preclinical overview of its two most advanced diabetic eye disease clinical candidates, THR-317 and THR-149, at EASDec 2018

Read more

SYMPOSIUM: Immuno-Oncology and Inflammation; Discovering New Scientific Frontiers

Read more

Ablynx: Notice In Relation To The Convertible Bonds Due May 2020

Read more

Biocartis Group NV: Study Demonstrates Ability of Idylla(TM) EGFR Mutation Test to Produce a Result in 80% of Failed Next Generation Sequencing Lung Cancer Tests

Read more

Update on mithra and mayne pharma’s vaginal contraceptive ring opportunity

Read more

Mithra announces further positive phase IBB Donesta® efficacy and safety data

Read more

Mithra signs binding heads of terms for commercialization of Estelle® in South Korea with women's health specialist Hyundai Pharm

Read more

argenx selected for BEL 20 Index

Read more

argenx receives feedback from FDA in end-of-phase 2 meeting for efgartigimod in myasthenia gravis

Read more

UGent Run4Brain

Read more

Daily newsflash - 13/06/2018

Read more

Galapagos Transparency notification

Read more

Sanofi complets its acquisition of Ablynx following the expiration of the squeeze-out procedure

Read more

CMAST attends the 2nd General Assembly of RESCEU; a European project focusing on the battle against RSV (June 21st-22nd, Oxford - UK)

Read more

The first veterinary stem cell product recommended for approval in Europe becomes a reality

Read more

Mithra: Publication of a Transparency Notification Received from François Fornieri

Read more

Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF

Read more

Mithra and Mediner sign LSA for Tibelia® in Hungary

Read more

Biocartis launches innovative Idylla(TM) MSI Assay

Read more

MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Top Pharma Partner

Read more

Mithra Obtains First Marketing Authorization for Myring™ in Europe

Read more

MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer

Read more

Promethera Biosciences Appoints Mutsuki Takano as General Manager of its Branch Office in Tokyo

Read more

Imec Onderzoeker Ontvangt Prestigieuze ERC Starting Grant voor de Ontwikkeling van Ultra-kleine Microscoop

Read more

Bone Therapeutics Notice of Half Year 2018 Results

Read more

argenx to Present at 2018 Wedbush PacGrow Healthcare Conference

Read more

Start with the end in Mind – Healthcare Market Access in the Digital Age

Read more

Workshop: Meet the Biobank Experts

Read more

argenx receives feedback from Japan's PMDA on Phase 3 clinical trial

Read more

Biocartis and Wondfo Announce Joint Venture for Commercialization of Idylla(TM) Platform in China

Read more

argenx doses first patient in global Phase 3 registration trial of efgartigimod for the treatment of generalized myasthenia gravis

Read more

GILEAD AND GALAPAGOS ANNOUNCE TORTUGA PHASE 2 STUDY OF FILGOTINIB IN ANKYLOSING SPONDYLITIS ACHIEVES PRIMARY ENDPOINT

Read more

Industry Insiders on the Future of Biopharma/Biotech in Belgium

Read more

Amerikaanse immunoloog Dr. James Allison wint de Dr. Paul Janssen Prijs voor Biomedisch Onderzoek

Read more

ThromboGenics Business Update - H1 2018

Read more

OPINNO BioBizz Café Roeselare

Read more

Mithra and Richter sign license and supply agreement for commercialization of Estelle®, a novel oral contraceptive

Read more

Patiëntenparticipatie doorheen de ontwikkelingscyclus van een geneesmiddel

Read more

OPINNO educational module Bruges: Get to know the life sciences industry and its various job opportunities

Read more

Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million

Read more

argenx announces launch of proposed public offering in the United States

Read more

OPINNO educational module Ghent: Get to know the life sciences industry and its various job opportunities

Read more

OPINNO educational module Brussels: Get to know the life sciences industry and its various job opportunities

Read more

V-Bio Ventures participates in 22.5 million euros series B financing round of HORAMA

Read more

Mithra signs exclusive license and supply agreement for commercialization of Tibelia® in Taiwan

Read more

Celyad Appoints Carri Duncan as Vice-President Corporate Development & Communications

Read more

Scale up! It’s time to grow for biotech companies!

Read more

Belgium-Korea Pharma-Bio Conference

Read more

Biocartis Group NV: Disclosure of outstanding voting securities

Read more

Mithra: 2018 update and 2019 outlook given at the cphi conference

Read more

ViroVet wins pitching competition

Read more

Bone Therapeutics announces single intra-articular injection of viscosupplement JTA-004 delivered higher pain reduction than the reference in first study in knee osteoarthritis

Read more

OPINNO BioBizz Café ICC Ghent

Read more

Galapagos phase 3 data on filgotinib in biologic-experienced rheumatoid arthritis to be presented at 2018 ACR/ARHP annual meeting

Read more

Galapagos: Positive trial results with filgotinib in psoriatic arthritis and ankylosing spondylitis both published in the lancet

Read more

argenx reports third quarter 2018 financial results and provides business update

Read more

BioBusiness Summer School

Read more

Galapagos reports initiation of PINTA Phase 2 trial with GLPG1205 in patients with Idiopathic Pulmonary Fibrosis (IPF)

Read more

Novosanis Colli-Pee approved by Mexican health authority

Read more

Next-Generation Protein Analysis and Detection (3rd edition)

Read more

V-Bio Ventures leads Camel-IDS EUR 37m Series A financing to develop cancer targeted radiopharmaceuticals

Read more

Mithra: full Estetrol (E4) program update provided at scientific advisory board meetings

Read more

Inbiose secures €4 million in debt financing

Read more

Novalis: Seed capital for biotech, with link to big data and AI

Read more

Life on chip: the road from idea to reality

Read more

MDxHealth Announces Approval for SelectMDx for Prostate Cancer by New York State

Read more

Biocartis Group NV: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX Genomic Prostate Score® Test

Read more

Mithra announces Myring™ update

Read more

Daily Newsflash - 21/12/2018

Read more

Daily newsflash - 02/01/2019

Read more

Daily Newsflash - 03/01/2019

Read more

Course: Radiation-induced effects with particular emphasis on genetics, development, teratology, cognition as well as space-related health issues

Read more

Daily newsflash - 04/01/2019

Read more

Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS

Read more

Fibrocor and Galapagos sign partnership in fibrosis

Read more

Daily Newsflash - 07/01/2019

Read more

Novosanis acquired by Orasure Technologies Inc

Read more

Daily Newsflash - 08/01/2018

Read more

Imec and TNO Launch Comfortable, Disposable Health Patch with Long Battery Life to Measure Vital Signs

Read more

Daily Newsflash - 9/01/2019

Read more

Daily Newflash - 10/01/2019

Read more

Daily Newsflash - 16/01/2019

Read more

Daily Newsflash - 17/01/2019

Read more

Mithra wins BelMid Company of the Year 2018

Read more

Daily Newsflash - 21/01/2019

Read more

Daily Newsflash - 22/01/2019

Read more

GSK Hackaton

Read more

Daily Newsflash - 28/01/2019

Read more

Daily Newsflash - 29/01/2019

Read more

Daily Newsflash - 30/01/2019

Read more

Daily Newsflash - 01/02/2019

Read more

argenx and Halozyme enter global collaboration and license agreement for ENHANZE® technology

Read more

Daily Newsflash - 04/02/2019

Read more

Daily Newsflash - 06/02/2019

Read more

EUROPE CEO

Read more

Evotec and Galapagos enter into collaboration in the field of fibrosis

Read more

Daily Newsflash - 07/02/2019

Read more

Daily Newsflash - 08/02/2019

Read more

Daily Newsflash - 20/02/2019

Read more

Daily Newsflash - 21/02/2019

Read more

Daily Newsflash - 22/02/2019

Read more

Daily Newsflash - 25/02/2019

Read more

Call for project ideas on Personalised Medicine

Read more

VIB, CD3 and Beactica announce drug discovery alliance targeting inflammatory diseases

Read more

Daily newsflash - 01/03/2019

Read more

Daily newsflash - 05/03/2019

Read more

Stop youth smoking with JLABS

Read more

Daily Newsflash - 07/03/2019

Read more

Daily Newsflash - 08/03/2019

Read more

The European Bank for induced pluripotent Stem Cells launches a second project phase

Read more

Daily Newsflash - 13/03/2019

Read more

START2PHARMA: CONTAMINATION CONTROL

Read more

START2PHARMA: VALIDATION FUNDAMENTALS: EQUIPMENT & SYSTEM QUALIFICATION

Read more

Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates

Read more

Daily Newsflash - 21/03/2019

Read more

The Innovative Medicines Initiative launches a public-private coordination and support action

Read more

Daily Newsflash - 22/03/2019

Read more

Plant immunity cut to size

Read more

Daily Newsflash - 25/03/2019

Read more

Benelux Precision Medicine Forum

Read more

Daily Newsflash - 29/03/2019

Read more

Daily Newsflash - 01/04/2019

Read more

Daily Newsflash - 02/04/2019

Read more

VIB: Artificial intelligence sheds new light on cell developmental dynamics

Read more

VIB: Edible antibodies to treat and prevent gastrointestinal disorders

Read more

Daily Newsflash - 03/04/2019

Read more

Structure of the molecular machine that links carbohydrate and lipid metabolism

Read more

Daily Newsflash - 04/04/2019

Read more

Daily Newsflash - 05/04/2019

Read more

Tijd om de wereld te veroveren

Read more

Daily Newsflash - 08/04/2019

Read more

Daily Newsflash - 09/04/2019

Read more

Daily newsflash - 12/04/2019

Read more

Daily Newsflash - 15/04/2019

Read more

Daily Newsflash - 17/04/2019

Read more

Mithra announces new agreement with GSP for development of an additional injectable

Read more

Daily Newsflash - 23/04/2019

Read more

Daily Newsflash - 24/04/2019

Read more

Daily Newsflash - 25/04/2019

Read more

Daily Newsflash - 26/04/2019

Read more

Daily Newsflash - 29/04/2019

Read more

Daily Newsflash - 02/05/2019

Read more

Daily Newsflash - 03/05/2019

Read more

Daily Newsflash - 07/05/2019

Read more

Promethera Biosciences Completes €39.7 Million ($44.4 Million) Series D Financing

Read more

Daily Newsflash - 09/05/2019

Read more

Daily Newsflash - 13/05/2019

Read more

Daily Newsflash - 15/05/2019

Read more

Daily Newsflash - 17/05/2019

Read more

SYMPOSIUM: Cellular Therapies in Oncology and Beyond: from Drug Development to Clinical Applications

Read more

Daily Newsflash - 22/05/2019

Read more

Free coaching session: I want to develop a medical device

Read more

JLABS Info Session Webinar

Read more

Daily Newsflash - 28/05/2019

Read more

eTheRNA: Appointment of Chief Financial Officer

Read more

Biocartis and Kite Sign Agreement for Development of Assays supporting Kite's Therapies

Read more

VIB: Towards a safer treatment for leukemia

Read more

Daily Newsflash - 04/06/2019

Read more

Daily Newsflash - 07/06/2019

Read more

Innovation Platforms & Projects

Read more

De Clercq & Partners: De beste IP-adviseur van de Benelux

Read more

Daily Newsflash - 14/06/2019

Read more

Daily Newsflash - 19/06/201

Read more

Daily Newsflash - 21/06/2019

Read more

Daily Newsflash - 25/06/2019

Read more

Daily Newsflash - 28/06/2019

Read more

Gilead announces intent to submit new drug application for filgotinib to U.S. food and drug administration this year

Read more

Celyad Announces Strategic Updates to the Autologous r/r AML and MDS Program

Read more

Daily Newsflash - 02/07/2019

Read more

Daily newsflash - 03/07/2019

Read more

Daily Newsflash - 04/07/2019

Read more

European Business Development Conference 2019

Read more

flanders.bio offers a wide range of advantages and services to its members

Read more

Member Directory

Read more

Biotech nieuws van de dag

Read more

ThromboGenics Achieves Important Milestone in the Development of THR-149

Read more

Promethera Biosciences Presents Preclinical Data on Novel H2Stem Cell Therapy at EASL International Liver Congress

Read more

Genohm releases the new version v5.4 of SLims

Read more

Nieuws van de dag - 25/04/2017

Read more

Genohm at ISBER 2017 in Toronto

Read more

ONTOFORCE and Ghent University launch a new innovative ‘text mining’ project

Read more

Nieuws van de dag - 28/04/2017

Read more

ThromboGenics NV : New ThromboGenics Ophthalmic Research Findings Presented at ARVO 2017 Annual Vision Research Meeting in Baltimore

Read more

Nieuws van de dag - 3/05/2017

Read more

argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in myasthenia gravis

Read more

MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics

Read more

Nieuws van de dag - 8/05/2017

Read more

VIB: Shortage of progranulin is a frequent cause of frontotemporal dementia

Read more

Pauwels Consulting neemt Vandycke & Partners en Mediconsult over

Read more

Biocartis Group NV: Biocartis announces its new CEO

Read more

FairJourney Biologics announces an innovative technology to discover antibody molecules in full therapeutic format

Read more

SelectMDx for Prostate Cancer Guides Patient Selection for mpMRI

Read more

Imec ontwikkelt implanteerbare microchip die gevoelservaring in protheses mogelijk maakt

Read more

Multiplicom launches complete CE-IVD marked solution in Europe for all BRCA testing needs

Read more

Nieuws van de dag- 18/05/2017

Read more

Nieuws van de dag- 30/05/2017

Read more

Scientists give tumor-fighting cells a boost in battling bone marrow cancer

Read more

Biocartis Group NV: MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

Read more

KWS en Bayer verlenen de eerste licentie voor herbiciden-tolerante suikerbiet aan SESVanderHave

Read more

Launch event of the Advanced Optical Microscopy Centre @ UHasselt

Read more

Daily Newsflash- 12/06/17

Read more

argenx to Present at JMP Securities Life Sciences Conference

Read more

Genohm at APHL 2017 in Providence

Read more

Daily Newsflash- 14/06/17

Read more

Daily Newsflash- 15/06/2017

Read more

ThromboGenics Long-time Non-executive Director Thomas Clay Appointed Chairman of the Board of Directors

Read more

MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test

Read more

Aphea.Bio aims at leading position in next generation agricultural biologicals

Read more

Galapagos' R&D Update 2017: rapidly advancing our product candidates

Read more

Daily Newsflash- 23/06/17

Read more

Ablynx achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc., Kenilworth, New Jersey, USA

Read more

flanders.bio strenghtens its team with the appointment of 3 Programme Managers

Read more

Daily Newsflash- 29/06/17

Read more

TiGenix opens US headquarters in Cambridge, MA

Read more

Daily Newsflash- 30/06/2017

Read more

Lack of Knowledge on Clinical Advances Achieved by New Generation of Biomarker Tests for Prostate Cancer

Read more

Daily newsflash- 4/07/2017

Read more

Leadership Seminar: Wednesdays in the Summer: Why DNA and Talent do matter

Read more

Daily Newsflash- 5/07/2017

Read more

Biocartis Group NV: Biocartis and A*STAR's ETPL initiate development of breast cancer assay to guide therapy selection

Read more

iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region

Read more

MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test

Read more

Celyad announces new agreements with Celdara medical and Dartmouth College

Read more

Dr. Paul Janssen Award for Biomedical Research

Read more

UgenTec receives €50.000 grant by European Union

Read more

New ThromboGenics' Ocriplasmin Clinical and Health Economic Data Presented at ASRS 2017 Annual Scientific Meeting in Boston

Read more

GREEN-CHEM: towards small footprint solutions

Read more

Genohm at the Global Biobank Week in Stockholm

Read more

Bijlage bij Knack vandaag: Fokus Research & Development

Read more

ONCURIOUS NV acquires unique portfolio of next-generation immuno-oncology assets from VIB

Read more

BioSeed® 2017

Read more

Genohm announced today the signing of several new clients

Read more

Ablynx to present at upcoming investor conferences in London

Read more

TiGenix strengthens US operations with senior appointments

Read more

OPINNO BioBizz Café Hasselt

Read more

Bone Therapeutics reports strong interim results from ALLOB® Phase IIA spinal fusion study

Read more

Daily Newsflash- 21/09/2017

Read more

Galapagos werft aan

Read more

ECCRT and Biotech Training Facility join forces to provide complementary trainings

Read more

ONTOFORCE and akcelis collaborate to create and share infographics

Read more

Voxdale Co-Creation Days

Read more

argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis

Read more

eTheRNA immunotherapies awarded €1 million grant from Flanders Innovation & Entrepreneurship

Read more

Daily Newsflash- 26/09/2017

Read more

Mithra Signs Commercial Agreement With Brazilian Leader in Women’s Health Libbs for Estelle® in Brazil

Read more

Confo Therapeutics start onderzoeks-samenwerking met Deens farmabedrijf Lundbeck

Read more

ThromboGenics Presenting THR-687 Preclinical Data at European Association for Vision and Eye Research (EVER) Meeting

Read more

BioFIT 2017

Read more

Ablynx files registration statement for a proposed global offering

Read more

Imec Reports Micro-Optomechanical Pressure Sensor Advancing Pressure Monitoring in Biomedical Applications

Read more

Imec Leverages the Power of Silicon Fabrication to Create Innovative Neural Probe Demonstrator with Unprecedented Electrode Density

Read more

Scientists pinpoint surprising origin of melanoma

Read more

Imec en de UGent openen HomeLab

Read more

BioTrinity 2018

Read more

Daily Newsflash- 23/10/2017

Read more

Bone Therapeutics to participate in upcoming key investor and partnering conferences in Q4 2017

Read more

Galapagos moving forward in CF programs at NACFC 2017

Read more

Versterk ons team! flanders.bio zoekt een Manager Communicatie & Events

Read more

Ablynx to present at upcoming investor conferences in London and Paris

Read more

Daily Newsflash- 10/11/2017

Read more

Daily Newsflash- 14/11/2017

Read more

Xendo awarded for the third year in a row as FD Gazelle

Read more

For the second year in a row ProDigest wins the Life Science Technology Award in the Deloitte Technology Fast 50 Competition

Read more

Biocartis Group NV: Idylla(TM) Performance Data Presented by US Key Opinion Leaders at Association for Molecular Pathology 2017 Conference

Read more

ALBATROSS with GLPG2222 shows positive clinical results in CF patients

Read more

TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting

Read more

Promethera Biosciences Provides Update on Executive Management Team

Read more

QualityKick as a worldwide first: QMS offered as a cloud-based, validated software solution for regulated sectors.

Read more

Biocartis launches CE-marked IVD RAS liquid biopsy tests developed under partnership with Merck KGaA, Darmstadt, Germany

Read more

Nieuwe lasertechniek om roetdeeltjes in lichaam te detecteren

Read more

Biocartis and Amgen Sign Companion Diagnostic Agreement for Idylla(TM) RAS Biomarker Tests

Read more

Daily Newsflash- 4/12/2017

Read more

Galapagos to enter NASDAQ Biotech Index

Read more

MedFIT - Fostering Innovation in medTech

Read more

Daily Newsflash - 14/12/2017

Read more

BIO CEO & Investor Conference

Read more

Bone Therapeutics Launches Equity Placement

Read more

Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae

Read more

Launch Interdisciplinary Program Translational Medicine I³h

Read more

Confo Therapeutics enters into drug discovery collaboration with Roche

Read more

Patient centricity in Clinical Research

Read more

flanders.bio steunt de ‘Homeless Webshop’ : de webshop zonder vast adres, om daklozen te steunen

Read more

Galapagos - Update on progress in cystic fibrosis programs

Read more

Takeda announces its intention to acquire TiGenix

Read more

Ablynx announces board changes

Read more

Daily Newsflash - 16/01/2017

Read more

ViroVet wins “start-up of the year” award

Read more

Biocartis & Immunexpress Sign Partnership for a Sepsis Host Immune Response Test on the Idylla(TM) platform

Read more

Sanofi to acquire Ablynx for €3.9 Billion

Read more

Colli-Pee recognized at the prestigious Henry Van de Velde Awards

Read more

Bekendmaking 5 genomineerde bedrijven voor de Foreign Investment of the Year Trophy 2018

Read more

Bone Therapeutics completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB®

Read more

Research and innovation on monitoring and control of infectious diseases (One Health)

Read more

Ablynx announces 2017 full year results

Read more

Key Considerations in Health Care Product Development

Read more

Daily Newsflash - 27/02/2018

Read more

Mithra Reports 2017 Annual Results

Read more

CMAST to participate in the bio-europe spring partnering conference

Read more

BCCM training on preservation of micro-organisms

Read more

Daily newsflash - 13/03/2018

Read more

Argenx awarded €2.5 million VLAIO grant to identify novel therapeutic antibodies

Read more

Ardena acquires ChemConnection adding API expertise

Read more

Naturejobs Career Expo London

Read more

Daily newsflash - 28/03/2018

Read more

Ablynx teams up with AIM for the design and implementation of its commercial supply chain for caplacizumab

Read more

Biocartis Group NV: Biocartis announces publication of its 2017 annual report

Read more

VIB: Molecular details of protein crystal nucleation uncovered

Read more

Hamilton Robotics first company to join the UgenTec’s new Molecular Automation Network

Read more

Daily newsflash - 10/04/2018

Read more

Daily newsflash - 11/04/2018

Read more

argenx to receive third preclinical milestone payment from collaboration with LEO Pharma

Read more

Daily newsflash - 12/04/2018

Read more

Daily newsflash - 17/04/2018

Read more

Daily newsflash - 18/04/2018

Read more

VIB presents its 2017 annual results and confirms its reputation as global player

Read more

Haematologica publishes Celyad THINK Study Case Report of CYAD-01 Induced Complete Remission in Relapsed/Refractory AML Patient

Read more

Daily newsflash - 03/05/2018

Read more

Human Biotech & Animal Health Business Partnering Summit

Read more

Seminar Financial Accounting and Audit in European Research & Development Funding

Read more

Daily newsflash - 14/05/2018

Read more

Daily newsflash - 15/05/2018

Read more

Press Release - Life Sciences & Biotechnology - 15/05/2018

Read more

Daily newsflash - 16/05/2018

Read more

Daily newsflash - 18/05/2018

Read more

Imec Packs New Fast Eye Tracking Technology into Ergonomic Design for High-Quality AR/VR Experiences

Read more

Webinar: A comprehensible jumpstart towards gcp computer system validation anno 2018

Read more

CMAST to participate in the bio international convention (Boston, us - 4-7 june, 2018)

Read more

Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix and Commencement of Second Acceptance Period

Read more

Bone Therapeutics announces results of Annual General Meeting

Read more

UgenTec opens US sales office

Read more

ThromboGenics Plans Name Change to "Oxurion"

Read more

Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis patients

Read more

Imaging interactions with fluorescence: from the nano-to-macro scale

Read more

SCK•CEN seminar to discover the latest innovations in nuclear medicine

Read more

CMAST: Horizon Europe – looking at the future or building on the past?

Read more

Galapagos: Topline results of PELICAN trial and update on triple combo development plans

Read more

Weekly newsflash - 12/07/2018

Read more

International Conference on Industrial Biotechnology and Bioprocessing

Read more

Weekly newsflash - 17/07/2018

Read more

flanders.bio zet in op nieuwe technologie en stoomt talent klaar voor een toekomst in de life sciences sector.

Read more

Xendo and its affiliate, Sofus Regulatory Affairs AB have been acquired by ProPharma Group

Read more

Novosanis obtains regulatory approval for Colli-Pee in Brazil

Read more

Innovation for Health 2019

Read more

Lessons in Herding Cats: Business Development for Life Science Companies

Read more

argenx announces that AbbVie has exercised its exclusive option to license ARGX-115, a novel immuno-oncology antibody

Read more

Biocartis Obtains Exclusive Worldwide License Rights for EGFR Ectodomain Mutations Determining Response

Read more

Bionection

Read more

OPINNO educational module Hasselt: Get to know the life sciences industry and its various job opportunities

Read more

Galapagos announces launch of proposed public offering

Read more

Galapagos raises $300 million gross proceeds in a U.S. public offering

Read more

Bone Therapeutics announces final results from Phase I/IIA ALLOB delayed-union fracture study

Read more

OPINNO educational module Leuven: Get to know the life sciences industry and its various job opportunities

Read more

Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients

Read more

Mithra Announces 2018 Half Year Results

Read more

BIO-Europe Spring® 2019 - Where the global biotech industry comes to partner

Read more

UgenTec to extend its software portfolio with FastTyper, a platform used for high-throughput SNP genotyping by end-point PCR

Read more

HR investment group Pyramid takes a stake in ORMIT

Read more

Daily Newsflash - 12/10/2018

Read more

Daily newsflash - 18/10/2018

Read more

Oxurion NV Business Update - Q3 2018

Read more

Daily newsflash - 19/10/2018

Read more

OPINNO BioBizz Café Gent

Read more

Daily newsflash - 30/10/2018

Read more

België is 'big in biotech'

Read more

Internationalization for Medtech and Biotech Startups

Read more

Daily Newsflash - 06/11/2018

Read more

BioWin Day 2018

Read more

ERS Genomics and Syngulon Sign License Agreement on CRISPR-Cas9 Genome Editing Patents for Industrial Applications

Read more

Daily Newsflash - 13/11/2018

Read more

New project launched to harmonize Clinical Data and develop a 21st Century Ecosystem for Real World Health Research in Europe

Read more

Galapagos transparency notification

Read more

Educational Workshop with PK-Sim® & MoBi® about PBPK Modeling & Simulation for Human Dose Projection and DDI Prediction

Read more

Biocartis and AstraZeneca Enter Into Agreement Aimed at Faster Lung Cancer Biomarker Results

Read more

Dirk Reyn has been appointed as chairman of the Board of Directors of flanders.bio

Read more

flanders.bio zoekt Programme Manager (EDUCATE) (m/v)

Read more

ECCRT Data Transparency Conference

Read more

Daily Newsflash - 12/12/2018

Read more

Daily Newsflash - 17/12/2018

Read more

Daily Newsflash - 18/12/2018

Read more

flanders.health ideation workshop

Read more

Daily Newsflash - 20/12/2017

Read more

Galapagos initiates NOVESA Phase 2a trial in patients with systemic sclerosis

Read more

Daily Newsflash - 23/01/2019

Read more

Daily Newsflash - 25/01/2019

Read more

Daily Newsflash - 31/01/2019

Read more

FDA Approves OCTIMET’s Investigational New Drug Application to evaluate OMO-1 in patients

Read more

Pharmafluidics’ new product launch steers ‘on-a-chip’ separations of complex biological samples to new heights

Read more

Daily Newsflash - 05/02/2019

Read more

OCTIMET has determined proof of target engagement in patient tumour tissue and a recommended phase II dose with OMO-1

Read more

Mithra Announces New Polymer Technology Development for a Leading Veterinarian Company

Read more

Agilent reikt Thought Leader Award uit aan

Read more

27/02/2019 - Daily Newsflash

Read more

Daily Newsflash - 04/03/2019

Read more

Daily Newsflash - 06/03/2019

Read more

flanders.bio supports HIHR

Read more

Daily Newsflash - 20/03/2019

Read more

Daily Newsflash - 26/03/2019

Read more

Daily Newsflash - 27/03/2019

Read more

Daily Newsflash - 28/03/2019

Read more

3e Job Tasting Day Advipro

Read more

VIB: From spinal cord injury to recovery

Read more

Daily Newsflash - 30/04/2019

Read more

Daily Newsflash - 06/05/2019

Read more

Daily Newsflash - 08/05/2019

Read more

Promethera Biosciences Announces First-Dosing in Phase 2a Clinical Study Evaluating World’s First Liver Stem Cell Therapy in Late-Stage NASH Patients

Read more

Daily Newsflash - 21/05/2019

Read more

Daily Newsflash - 23/05/2019

Read more

Daily Newsflash - 24/05/2019

Read more

Daily Newsflash - 27/05/2019

Read more

Info day: I want to learn about the Medical Technology industry

Read more

Nutrition and the Journey of Cancer

Read more

Daily Newsflash - 31/05/2019

Read more

Daily Newsflash - 05/06/2019

Read more

VIB: Salty diet reduces tumor growth by tackling immune cells

Read more

How to Hold Your First-In-Human Trial?

Read more

Daily Newsflash - 20/06/2019

Read more

Daily Newsflash - 26/06/2019

Read more

Daily Newsflash - 27/06/2019

Read more

Lecture: "Hunting for antibiotics and anticancer compounds made by bacteria"

Read more

flanders.bio events

Read more

flanders.bio member events

Read more

Persoverzicht - 20-21/04/207

Read more

Celyad grants to Novartis a non-exclusive license for its allogeneic TCR-deficient CAR-T cells patents

Read more

Nieuws van de dag - 2/05/2017

Read more

Celyad to Present at the Deutsche Bank 42nd Annual Health Care Conference

Read more

Nieuws van de dag- 5/05/2017

Read more

Nieuws van de dag- 9/05/2017

Read more

Imec maakt zelflerende chip geïnspireerd op het menselijk brein

Read more

Nieuws de dag- 10//05/2017

Read more

Genohm at Pathology Informatics Summit 2017 in Pittsburgh

Read more

Nieuws van de dag- 11/05/2017

Read more

Nieuws van de dag- 12/05/2017

Read more

VIB: Researchers identify nutrient metabolism that drives breast tumor metastasis

Read more

Nieuws van de dag- 15/05/2017

Read more

Nieuws van de dag- 16/05/2017

Read more

ViroVet and GALVmed to collaborate on novel vaccines for sheep & goats

Read more

Nieuws van de dag- 17/05/2017

Read more

Galapagos to hold Annual R&D Update 2017 on 20 June

Read more

Tau prevents synaptic transmission at early stage of neurodegeneration

Read more

Nieuws van de dag- 22/05/217

Read more

Genohm releases new SLims Workflow for NIPT

Read more

Nieuws van de dag- 29/05/2017

Read more

Celyad obtains additional US patent for cancer treatment

Read more

Genohm at SEASR 2017 in Tampa

Read more

Nieuws van de dag- 01/06/2017

Read more

Daily Newsflash- 7/06/2017

Read more

Daily Newsflash- 8/06/2017

Read more

Services

Read more

Daily Newsflash- 13/06/17

Read more

REGMED Europe

Read more

Daily Newsflash- 16/06/17

Read more

Symposium on Liquid Biopsies & Cancer

Read more

Daily Newsflash- 19/06/17

Read more

A diagnostic test for ALS

Read more

argenx receives second preclinical milestone payment in collaboration with LEO Pharma

Read more

Celyad publishes additional pre-clinical data in support of THINK trial

Read more

Daily Newsflash- 22/06/17

Read more

Daily Newsflash- 26/06/17

Read more

UgenTec moves into PCR middleware, partners with Haman Laborautomation

Read more

Promethera Announces Review Acceptance of Heparesc New Drug Submission for Neonatal Onset Urea Cycle Disorders by Health Canada

Read more

bionection – Partnering Conference for Technology Transfer in Life Sciences

Read more

argenx presents full data from ARGX-111 Phase Ib study in patients with advanced cancers over-expressing the MET protein

Read more

BioInvent and ThromboGenics Amending Long-Standing Monoclonal Antibody Development Agreement

Read more

QBD Webinar on validation of mobile apps

Read more

Mithra Submits Myring™ for European Marketing Approval

Read more

Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’s disease

Read more

Daily Newsflash- 1/08/2017

Read more

Interreg 2 Seas Project DERMA Industrial Matchmaking and Showcase Event

Read more

ALTIUS Pharma & Life Sciences seminar

Read more

Daily Newsflash- 10/08/2017

Read more

Daily Newsflash- 11/08/20111

Read more

Navigation and spatial memory: new brain region identified to be involved

Read more

Ablynx will announce its 2017 half year results with webcast on 24 august 2017

Read more

Scientists unravel role of glutamine synthetase in the spread of cancer

Read more

Daily Newsflash- 21/08/2017

Read more

argenx announces publication of preclinical data supporting the therapeutic potential of SIMPLE AntibodyTM ARGX-116

Read more

Daily Newsflash- 1/09/2017

Read more

TiGenix obtains commercial production license for expanded manufacturing facility

Read more

Daily Newsflash- 5/09/2017

Read more

Daily Newsflash- 11/09/2017

Read more

Daily Newsflash- 12/09/2017

Read more

Daily Newsflash- 13/09/2017

Read more

Daily Newsflash- 14/09/2017

Read more

Daily Newsflash- 15/09/2017

Read more

ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)

Read more

Daily Newsflash- 18/09/2017

Read more

Daily Newsflash- 19/09/2017

Read more

argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in immune thrombocytopenia

Read more

Daily Newsflash- 25/09/2017

Read more

Biotech Showcase™ 2018

Read more

Genohm at ASHG 2017 in Orlando, FL

Read more

Daily Newsflash- 29/09/2017

Read more

Trainings

Read more

Daily Newsflash- 04/10/2017

Read more

Promethera Biosciences and Shibuya Announce Strategic Collaboration to Establish Breakthrough Cell Therapy Manufacturing Platform

Read more

Mithra’s Marketing Authorization Application for Tibelia® Accepted by Health Canada

Read more

Daily Newsflash- 10/10/2017

Read more

Pauwels Consulting acquires Akros Solutions

Read more

Daily Newsflash- 11/10/2017

Read more

QM Conference: Partnerships in Quality Management

Read more

Daily Newsflash- 12/10/2017

Read more

Daily Newsflash- 13/10/2017

Read more

Daily Newsflash- 16/10/2017

Read more

Kankercongres.be: Meer dan 300 deelnemers krijgen op 21 oktober meer informatie over kankeronderzoek en toekomstige behandelingen

Read more

Newly described process in Parkinson’s protein as a potential new therapy route

Read more

Daily Newsflash- 19/10/2017

Read more

ThromboGenics Business Update - Q3 2017

Read more

TiGenix granted Orphan Drug Designation from the U.S. FDA for Cx601

Read more

Daily Newsflash- 24/10/2017

Read more

GAMIAN-Europe & CMAST announce collaborative partnership

Read more

Daily Newsflash- 27/10/2017

Read more

argenx launches Phase I trial with subcutaneous formulation of ARGX-113

Read more

Daily Newsflash- 6/11/2017

Read more

OCTIMET Oncology NV awarded €1.12 million grant from VLAIO

Read more

Daily Newsflash- 13/11/2017

Read more

Life Sciences Baltics 2018

Read more

Daily Newsflash- 15/11/2017

Read more

Daily Newsflash- 16/11/2017

Read more

Count your blessings: Quantitative Microbiome Profiling

Read more

Imec en partners ontwikkelen Internet-of-Things systeem met sensor-en robottechnologie die gepersonaliseerde interactie met zorgbehoevende ouderen mogelijk maakt

Read more

Daily Newsflash- 17/11/2017

Read more

Expertise - 23/11/2017

Read more

Daily Newsflash- 24/11/2017

Read more

Daily Newsflash- 30/11/2017

Read more

Scientists shed light on a tumor-suppressive protein In metastases

Read more

Daily Newsflash - 11/12/2017

Read more

Press Release - Life Sciences & Biotechnology

Read more

Galapagos NV - Transparency notification

Read more

Daily Newsflash - 12/12/2017

Read more

Galapagos exercises co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries

Read more

Daily Newsflash - 15/12/2017

Read more

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease

Read more

Bone Therapeutics Provides Update on Equity Placement

Read more

Daily Newsflash - 18/12/2017

Read more

Daily Newsflash - 19/12/2017

Read more

Daily Newsflash - 21/12/2017

Read more

Biocartis and Amgen Sign New Companion Diagnostic Agreement for Novel Oncology Compound

Read more

Daily Newsflash - 9/01/2018

Read more

Daily Newsflash - 10/01/2018

Read more

VIB, CD3 and Galapagos NV enter into a license deal for the development of MALT1 inhibitors

Read more

Daily Newsflash - 11/01/2018

Read more

Daily Newsflash - 12/01/2018

Read more

Daily Newsflash - 15/01/2018

Read more

Daily Newsflash - 17/01/2018

Read more

Scientists shed light on a key molecular mechanism of autoimmune and inflammatory diseases

Read more

Daily Newsflash - 18/01/2018

Read more

Daily Newsflash - 19/01/2018

Read more

Scientists discover how treating eczema could also alleviate asthma

Read more

New collaboration between VIB and Plant Impact plc: advancing crop enhancement small molecule discovery

Read more

Mithra Announces Last Subject Completes Donesta® Phase II Study

Read more

Daily Newsflash - 26/01/2018

Read more

Daily Newsflash - 1/02/2018

Read more

Closing in on Tau: Researchers identify a new synaptic player in early stages of neurodegeneration

Read more

HDAC6 inhibitors protect against neuronal damage and have therapeutic potential in both neurology and oncology

Read more

Daily Newsflash - 12/02/2018

Read more

Wereldrecord genoomanalyse dankzij Leuvense software

Read more

Daily Newsflash - 13/02/2018

Read more

Persbericht - Life Sciences & Biotechnologie - 13/02/2018

Read more

Daily Newsflash - 14/02/2018

Read more

Daily Newsflash - 15/02/2018

Read more

Daily Newsflash - 16/02/2018

Read more

Daily Newsflash - 19/02/2018

Read more

Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer’s disease

Read more

Scientists discover how to increase both sugar yield and biomass production in the model plant Arabidopsis

Read more

Daily Newsflash - 1/03/2018

Read more

Daily Newsflash - 02/03/2018

Read more

Daily newsflash - 14/03/2018

Read more

So hot it hurts - Leuven researchers uncover ion channel trio that mediates painful heat sensing

Read more

Daily Newsflash - 15/03/2018

Read more

Daily newsflash - 16/03/2018

Read more

Daily newsflash - 19/03/2018

Read more

Argenx announces expansion of its pipeline with addition of complement-targeted ARGX-117 for treatment of severe autoimmune diseases

Read more

European scientists unite to track all cells in the human body

Read more

Celyad Reports 2017 Financial and Operating Results and Expected Key Milestones for 2018

Read more

Daily Newsflash - 23/03/2018

Read more

argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis in Europe

Read more

Daily newsflash - 27/03/2018

Read more

Daily newsflash - 29/03/2018

Read more

Novosanis’ medical device Colli-Pee® prefilled with urine preservative now CE-certified

Read more

Daily newsflash - 30/03/2018

Read more

Daily newsflash - 03/04/2018

Read more

Daily newsflash - 04/04/2018

Read more

Daily newsflash - 05/04/2018

Read more

Daily newsflash - 06/04/2018

Read more

Daily newsflash - 09/04/2018

Read more

Daily newsflash - 13/04/2018

Read more

Daily newsflash - 16/04/2018

Read more

Daily Newsflash - 19/04/2018

Read more

Daily Newsflash - 20/04/2018

Read more

Daily newsflash - 23/04/2018

Read more

Bone Therapeutics Strengthens Board with the Appointment of Claudia D’Augusta as Non-Executive Director

Read more

ThromboGenics Initiates Phase 2 Clinical Study Evaluating anti-PlGF (THR-317) in combination with anti-VEGF (ranibizumab) for treatment of Diabetic Macular Edema (DME)

Read more

Daily newsflash - 27/04/2018

Read more

Daily newsflash - 02/05/2018

Read more

Imec demonstrates direct optical reading of single-molecule DNA bases in modified nanopores

Read more

Daily newsflash - 08/05/2018

Read more

Daily newsflash - 11/05/2018

Read more

Promethera Biosciences Establishes Branch Office in Tokyo

Read more

Daily newsflash - 24/05/2018

Read more

VIB: New genes found only in humans shed light on unique features of brain development

Read more

MDxHealth Annual General Shareholders' Meeting

Read more

Biotechdag 2018: Geneeskunde op maat

Read more

Daily newsflash - 11/06/2018

Read more

Daily newsflash - 12/06/2018

Read more

Daily Newsflash - 14/06/2018

Read more

Daily newsflash - 15/06/2018

Read more

Daily newsflash - 18/06/2018

Read more

Daily newsflash - 19/06/2018

Read more

Daily newsflash - 02/07/2018

Read more

Daily Newsflash - 6/07/2018

Read more

INNOVATION TRANSFORMING HEALTH CARE

Read more

argenx receives milestone payment from strategic collaboration with Shire

Read more

EIT Health Investor Forum

Read more

OCTIMET Oncology NV awarded €1.077 million R&D grant from VLAIO

Read more

Rejuvenate Biomed awarded €460,000 grant from VLAIO to accelerate drug development for healthy aging

Read more

Weekly Newsflash - 16/08/2018

Read more

Why Ya Buggin’ Out? Regulatory Hurdles and Other Obstacles on the Path to Microbiome Market

Read more

Celyad Reports First Half 2018 Financial Results and Operational Progress

Read more

Weekly Newsflash - 23/08/2018

Read more

Daily newsflash - 28/08/2018

Read more

ThromboGenics becomes "Oxurion"

Read more

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy

Read more

Daily newsflash - 10/09/2018

Read more

Daily newsflash - 11/09/2018

Read more

Daily newsflash - 12/09/2018

Read more

Mithra announces further details regarding contract gedeon richter

Read more

Daily newsflash - 13/09/2018

Read more

De chemie is goed voor België (en omgekeerd)

Read more

Daily newsflash - 14/09/2018

Read more

Daily newsflash - 17/09/2018

Read more

Daily newsflash - 18/09/2018

Read more

ViroVet receives grant from VLAIO (Flanders) to boost the development of its disruptive vaccine technology

Read more

Daily newsflash - 19/09/2018

Read more

de clercq & partners annual ip seminar

Read more

Webinar commercializing on your own: panel discussion with insights from emerging biopharma executives

Read more

Mithra Finalizes Contract for the Commercialization of Estelle® with South Korean Women's Health Leader Hyundai Pharm

Read more

Daily Newsflash - 26/09/2018

Read more

Presentation of Donesta® PHIIB results at the 2018 annual meeting of the North American menopause society

Read more

Daily newsflash - 10/10/2018

Read more

Daily newsflash - 11/10/2018

Read more

Daily Newsflash - 15/10/2018

Read more

Daily newsflash - 16/10/2018

Read more

Daily newsflash - 17/10/2018

Read more

Daily newsflash - 23/10/2018

Read more

Bone Therapeutics announces appointment of Linda Lebon as Chief Regulatory Officer

Read more

Oxurion NV Announces the Appointment of Adrienne Graves to its Board of Directors

Read more

Daily newsflash - 02/11/2018

Read more

SWAT4(HC)LS 2018

Read more

Daily newsflash - 12/11/2018

Read more

Daily Newsflash - 14/11/2018

Read more

Daily newsflash - 15/11/2018

Read more

Daily newsflash - 16/11/2018

Read more

Daily newsflash - 19/11/2018

Read more

Daily newsflash - 23/11/2018

Read more

Daily Newsflash - 28/11/2018

Read more

Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis

Read more

Daily newsflash - 30/11/2018

Read more

Janssen intensifieert samenwerking met KU Leuven, KU Leuven Research & Development en UZ Leuven

Read more

Biotech Showcase™ 2019

Read more

Daily Newsflash - 10/12/2018

Read more

Daily Newsflash - 11/12/2018

Read more

Daily Newsflash - 13/12/2018

Read more

Daily Newsflash - 14/12/2018

Read more

Galapagos reports initiation of ISABELA Phase 3 program with GLPG1690 in patients with Idiopathic Pulmonary Fibrosis (IPF)

Read more

Daily Newsflash - 19/12/2018

Read more

Invite to flanders.bio's Salary Survey

Read more

Lunch & Learn with Allen & Overy: Legal Challenges of a Start-up

Read more

Effective & Business Value-Oriented Patents

Read more

BIO Investor Forum

Read more

Genohm at #kfg2017, the 2017 Edition of Knowledge for Growth in Ghent

Read more

Genohm at #eshg2017 in Copenhagen

Read more

Novel Nanobody to start clinical development in osteoarthritis - ablynx to receive €15 Million milestone payment

Read more

Innovative software Moon autonomously diagnoses rare diseases within minutes

Read more

Nieuws van de dag- 23/05/2017

Read more

Nieuws van de dag- 24/05/2017

Read more

Nieuws van de dag- 31/05/2017

Read more

Daily newsflash- 2/06/2017

Read more

Daily Newsflash- 6/06/2017

Read more

Daily Newsflash- 9/06/2017

Read more

Internationalisation

Read more

Daily Newsflash- 20/06/17

Read more

BCCM training: New developments in gene and plasmid technology

Read more

Daily Newsflash- 21/06/17

Read more

Expertise

Read more

Daily Newsflash - 28/06/2017

Read more

Daily Newsflash- 3/07/2017

Read more

Membership Information

Read more

Daily Newsflash- 6/07/2017

Read more

Daily Newsflash- 7/07/2017

Read more

Delphi Genetics receives GMP accreditation for plasmid DNA bioproduction

Read more

Ablynx & Sanofi enter into a strategic collaboration to develop nanobody product candidates

Read more

Ablynx receives fast track designation from the FDA for Caplacizumab for the treatment of acquired TTP

Read more

Daily Newsflash- 31/07/2017

Read more

Daily Newsflash- 2/08/2017

Read more

Genohm: SLIMS just got better!

Read more

Daily Newsflash- 3/08/2017

Read more

Daily Newsflash- 4/08/2017

Read more

Daily Newsflash- 7/08/2017

Read more

Daily Newsflash- 8/08/2017

Read more

Daily Newsflash- 9/08/2017

Read more

Daily Newsflash- 23/08/2017

Read more

Personal Invitation

Read more

Daily Newsflash- 24/08/2017

Read more

Daily Newsflash- 28/08/2017

Read more

Dosing of First Patient with investigational agent OMO-1

Read more

Daily Newsflash- 29/08/2017

Read more

Daily Newsflash- 30/08/2017

Read more

Genohm releases new SLIMS overview video

Read more

Daily Newsflash- 31/08/2017

Read more

Daily Newsflash- 4/09/2017

Read more

Daily Newsflash- 6/09/2017

Read more

Daily Newsflash- 7/09/2017

Read more

Daily Newsflash- 8/09/2017

Read more

Genomic Health and Biocartis Announce Agreement to Develop an Idylla(TM) IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access

Read more

Bijlage bij De Standaard: Innovatie

Read more

Expertise - FUND

Read more

Ardena launches following Pharmavize and Crystallics merger

Read more

Daily Newsflash- 20/09/2017

Read more

Bone Therapeutics and Asahi Kasei sign exclusive license agreement for PREOB® in Japan

Read more

Daily Newsflash- 22/09/2017

Read more

Trainings - CONNECT / EDUCATE

Read more

Daily Newsflash- 27/09/2017

Read more

Internationalisation - FUND

Read more

Daily Newsflash- 28/09/2017

Read more

Chemcys 2018

Read more

ThromboGenics Successfully Introduces New 'Already-Diluted' Formulation of JETREA® (ocriplasmin) in the US

Read more

Daily Newsflash- 02/10/2017

Read more

Daily Newsflash- 3/10/2017

Read more

Press Release flanders.bio

Read more

Daily Newsflash- 5/10/2017

Read more

Telenet en imec gaan samenwerken rond Internet of Things en Smart Cities

Read more

Daily Newsflash- 6/10/2017

Read more

ThromboGenics announces publication in Experimental Eye Research of preclinical data supporting therapeutic potential of THR-317 in DR

Read more

Daily Newsflash- 9/10/2017

Read more

Newsflash

Read more

Ablynx establishes subsidiary in the USA and appoints a general manager

Read more

Networking

Read more

Press Release

Read more

Daily Newsflash- 20/10/2017

Read more

Daily Newsflash- 25/10/2017

Read more

Daily Newsflash- 26/10/2017

Read more

Daily Newsflash- 7/11/2017

Read more

Daily Newsflash- 8/11/2017

Read more

Daily Newsflash- 9/11/2017

Read more

TiGenix announces approval of trade name for lead development candidate Cx601 in Europe

Read more

Genohm: ISO 9001:2015 Certification - It’s a Big Deal

Read more

Daily Newsflash- 20/11/2017

Read more

Daily Newsflash- 21/11/2017

Read more

Daily Newsflash- 22/11/2017

Read more

Daily Newsflash- 23/11/2017

Read more

A Practical Guide to MiFID II

Read more

Daily Newsflash- 27/11/2017

Read more

Trainings - EDUCATE

Read more

Daily Newsflash- 28/11/2017

Read more

Daily Newsflash- 29/11/2017

Read more

Fast Track Diagnostics and UgenTec announce new interpretation software for all FTD real-time PCR multiplex kits

Read more

Daily Newsflash- 5/12/2017

Read more

The Adecco Group Announces the Acquisition of CMAST

Read more

Daily Newsflash- 6/12/2017

Read more

Daily Newsflash - 7/12/2017

Read more

Patient Enrolment in Phase II CIRCLE Study Evaluating THR-409 (ocriplasmin) for Non-Proliferative Diabetic Retinopathy (NPDR) Discontinued due to Slow Recruitment Rate

Read more

Daily Newsflash - 8/12/2017

Read more

Bone Therapeutics and Cellthera Pharm LLC announce intention to collaborate and Bone Therapeutics provides overview of its pipeline

Read more

Expertise - 10/01/2018

Read more

Press Release - Life Sciences & Biotechnology - 14/12/2017

Read more

Persbericht - Life Sciences & Biotechnologie - 14/12/2017

Read more

New at Poulpharm: Animal facility for studies demanding high-containment levels

Read more

Trainings - 19/12/2017

Read more

Ablynx announces positive data from its Japanese ethno-bridging study of Caplacizumab

Read more

Ablynx to present at the 36th annual J.P. Morgen Healthcare conference

Read more

Daily Newsflash - 8/01/2018

Read more

PharmaFluidics raises 7.3 million euro to expand commercialization of novel micro-chip device for biomarker, diagnostics and drug development applications

Read more

Trainings - 15/01/2018

Read more

TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601 (darvadstrocel) in the treatment of complex perianal fistulas in Crohn’s disease

Read more

Press Release - Life Sciences & Biotechnology - 17/01/2018

Read more

Persbericht - Life Sciences & Biotechnologie - 17/01/2018

Read more

Daily Newsflash - 22/01/2018

Read more

Daily Newsflash - 23/01/2018

Read more

UgenTec and MDxHealth sign partnership agreement for software to support interpretation of molecular test results

Read more

Daily Newsflash - 24/01/2018

Read more

Daily Newsflash - 25/01/2018

Read more

Daily Newsflash - 29/01/2018

Read more

Daily Newsflash - 30/01/2018

Read more

Daily Newsflash - 31/01/2018

Read more

Daily Newsflash - 5/02/2018

Read more

Daily Newsflash - 6/02/2018

Read more

Press Release - Life Sciences & Biotechnology - 7/02/2018

Read more

Persbericht - Life Sciences & Biotechnologie - 7/02/2018

Read more

Daily Newsflash - 7/02/2018

Read more

Daily Newsflash - 8/02/2018

Read more

Daily Newsflash - 09/02/2018

Read more

Daily Newsflash - 20/02/2018

Read more

Daily Newsflash - 21/02/2018

Read more

Daily Newsflash - 22/02/2018

Read more

Daily Newsflash - 23/02/2018

Read more

Daily Newsflash - 26/02/2018

Read more

Daily Newsflash - 28/02/2018

Read more

CMAST supports Rejuvenate Biomed in their search for ways to impact the ageing process

Read more

Kaneka (JP), Pfizer (VS) en Brolis (LT) winnen op de Foreign Investment Trophy 2018

Read more

Daily Newsflash - 2/03/2018

Read more

Daily Newsflash - 06/03/2018

Read more

Bone Therapeutics announces private placement of convertible bonds

Read more

Daily newsflash - 07/03/2018

Read more

Daily newsflash - 08/03/2018

Read more

Daily Newsflash - 09/03/2018

Read more

Daily newsflash - 20/03/2018

Read more

Daily newsflash - 21/03/2018

Read more

Daily newsflash - 22/03/2018

Read more

Daily newsflash - 26/03/2018

Read more

Networking - 14/06/2018

Read more

ThromboGenics announces publication in The Journal of Medicinal Chemistry of preclinical data

Read more

Promethera Biosciences Presents Novel Data on HepaStem’s Ability to Reduce Key Disease Parameters in Advanced Stage NASH in vivo Model

Read more

Reminder: Invite to flanders.bio's Salary Survey

Read more

Mithra Announces Positive Donesta® Phase IIb Study Achieving Primary Objective and Confirming Promising Safety Profile

Read more

Daily newsflash - 24/04/2018

Read more

Galapagos reports initiation of FALCON clinical trial in cystic fibrosis

Read more

Daily newsflash - 25/04/2018

Read more

Daily newsflash - 26/04/2018

Read more

Daily newsflash - 04/05/2018

Read more

Daily newsflash - 07/05/2018

Read more

Daily newsflash - 09/05/2018

Read more

Persbericht - Life Sciences & Biotechnologie - 11/05/2018

Read more

Press Release - Life Sciences & Biotechnology - 18/05/2018

Read more

Daily Newsflash - 22/05/2018

Read more

Daily newsflah - 23/05/2018

Read more

Daily newsflash - 25/05/2018

Read more

Daily newsflash - 28/05/2018

Read more

Daily newsflash - 29/05/2018

Read more

Daily newsflash - 30/05/2018

Read more

Daily newsflash - 31/05/2018

Read more

Daily newsflash - 01/06/2018

Read more

Daily newsflash - 04/06/2018

Read more

Daily newsflash - 05/06/2018

Read more

Daily newsflash - 06/06/2048

Read more

Daily newsflash - 07/06/2018

Read more

Daily newsflash - 08/06/2018

Read more

Daily newsflash - 20/06/2018

Read more

Daily newsflash - 21/06/2018

Read more

Daily Newsflash - 22/06/2018

Read more

Daily newsflash - 25/06/2018

Read more

Daily newsflash - 26/06/2018

Read more

Genohm: SLIMS Version 6.2 has been Released

Read more

Daily newsflash - 27/06/2018

Read more

Daily newsflash - 28/06/2018

Read more

Daily newsflash - 29/06/2018

Read more

Daily newsflash - 03/07/2018

Read more

Daily newsflash - 04/07/2018

Read more

Daily newsflash - 05/07/2018

Read more

Weekly newsflash - 26/07/2018

Read more

Weekly newsflash - 02/08/2018

Read more

Weekly newsflash - 09/08/2018

Read more

Daily newsflash - 27/08/2018

Read more

Daily newsflash - 29/08/2018

Read more

Daily newsflash - 30/08/2018

Read more

Daily newsflash - 31/08/2018

Read more

Communicating Toxicology: What’s the Risk ?

Read more

Daily newsflash - 03/09/2018

Read more

Daily newsflash - 04/09/2018

Read more

Daily newsflash - 05/09/2018

Read more

Daily newsflash - 06/09/2018

Read more

Daily newsflash - 07/09/2018

Read more

Oxurion NV Announces New NYSE Euronext Brussels Stock Ticker "OXUR" and Launch of New Website

Read more

Galapagos issues new shares as result of public offering

Read more

Press Release - Life Sciences & Biotechnology - 18/09/2018

Read more

Persbericht - Life Sciences & Biotechnologie - 18/09/2018

Read more

Daily newsflash - 20/09/2018

Read more

Daily newsflash - 21/09/2018

Read more

Bone Therapeutics to present at 26th Annual Meeting of the European Orthopaedic Research Society

Read more

Daily Newsflash - 24/09/2018

Read more

Daily Newsflash - 25/09/2018

Read more

Daily Newsflash - 27/09/2018

Read more

Daily Newsflash - 28/09/2018

Read more

PharmaFluidics Facilitates Ultra-high-resolution Proteomics Analysis Through Agreement with Thermo Fisher Scientific

Read more

Daily newsflash - 01/10/2018

Read more

Daily newsflash - 02/10/2018

Read more

Daily newsflash - 03/10/2018

Read more

Daily newsflash - 04/10/2018

Read more

Daily Newsflash - 5/10/2018

Read more

Daily newsflash - 08/10/2018

Read more

argenx awarded €2.6 million VLAIO grant to explore new applications of ABDEG technology

Read more

Daily newsflash - 09/10/2018

Read more

Kleur bekennen voor de chemie en farma van de toekomst

Read more

Essenscia innovation award 2019

Read more

ONTOFORCE and ChemAxon facilitate linked chemical data search

Read more

Persbericht - Life Sciences & Biotechnologie - 12/10/2018

Read more

Daily newsflash - 22/10/2018

Read more

Oxurion NV Extends Partnership with Retina Global in Support of Bolivian Diabetic Retinopathy (BOLDR) Project

Read more

Daily Newsflash - 24/10/2018

Read more

Galapagos and AbbVie restructure CF collaboration

Read more

Daily newsflash - 25/10/2018

Read more

Johnson & Johnson opent in Leiden nieuwe Vaccines Launch Facility

Read more

Daily newsflash - 26/10/2018

Read more

Daily newsflash - 29/10/2018

Read more

3e Job Tasting Advipro

Read more

Daily Newsflash - 31/10/2018

Read more

Imec Releases Neuropixels Neural Probe to the Global Neuroscience Community

Read more

Daily newsflash - 05/11/2018

Read more

Oxurion and Beta Therapeutics To Develop New Heparanase Inhibitors for Treatment of dry AMD

Read more

PwC enters into strategic partnership with flanders.bio as of October 1st, 2018

Read more

Daily newsflash - 07/11/2018

Read more

Daily newsflash - 08/11/2018

Read more

Daily newsflash - 09/11/2018

Read more

BiR&D Cross-Disciplinary PhD Award

Read more

Daily Newsflash - 20/11/2018

Read more

Daily newsflash - 21/11/2018

Read more

Daily newsflash - 22/11/2018

Read more

Daily newsflash - 26/11/2018

Read more

Daily Newsflash - 27/11/2018

Read more

Daily newsflash - 29/11/2018

Read more

Daily newsflash - 03/12/2018

Read more

Daily newsflash - 04/12/2018

Read more

Daily Newsflash - 05/12/2018

Read more

Daily Newsflash - 06/12/2018

Read more

Daily Newsflash - 7/12/2018

Read more

Survey : Tell us what courses and internships you are interested in?

Read more

Opportunity: GSK Hackaton

Read more

Save the date: General Assembly

Read more

Thank you for attending!

Read more

Call for candidacies for the Board of Directors of flanders.bio

Read more

Membership Satisfaction Survey

Read more

Follow-up information General Assembly flanders.bio 2019

Read more

BREAKING: FLANDERS INVESTS IN PERSONALISED MEDICINE

Read more

flanders.bio internationalisation: Flemish Life Sciences & Biotech Week Japan

Read more

Invitation: Join the Helis Academy Data Analysis & Stewardship Courses

Read more

Invitation: Second edition Hot in Healthcare

Read more

flanders.bio internationalisation: Last call Flemish Life Sciences & Biotech Week Japan

Read more

Tips & tricks om je cv te pimpen

Read more

flanders.bio internationalisation: BIO-EUROPE 2019

Read more

Deep Dive - 07/11/2019

Read more

Ecosynth moves to new laboratories

Read more

Service: your internship(s) on the flanders.bio website

Read more

flanders.bio lidmaatschap

Read more

flanders.bio Trainings: Info Session MBI Life Sciences & Health Academy 2017-2018

Read more

Thank you for your cooperation!

Read more

Isomorphic Software shares a case study on Genohm

Read more

Persbericht - Life Sciences & Biotechnologie

Read more

Last Chance to Register for our Quality Expert Session

Read more

Bio€quity is coming to Ghent - Make your mark!

Read more

flanders.bio Educate: Opinno Module 1

Read more

flanders.bio membership

Read more

Follow-up info flanders.bio-CMAST Partner Day

Read more

Networking - 01/03/2018

Read more

Press Release - Life Sciences & Biotechnology - 2/02/2018

Read more

Service - 20/02/2018

Read more

Networking - 28/02/2018

Read more

Supporting New Initiatives 8/03/2018

Read more

Galapagos publication of the annual report and invitation to the annual shareholders' meeting

Read more

Towards high-quality Cell Therapy

Read more

Press Release - Life Sciences & Biotechnology - 30/03/2018

Read more

UgenTec Announces partnership with Serosep Ltd.

Read more

Thank you for attending the latest flanders.bio - Roche Diagnostics Partner Day

Read more

Internationalisation 24/09/2018 - 26/09/2018

Read more

Press Release - Life Sciences & Biotechnology - 23/07/2018

Read more

Press Release - Life Sciences & Biotechnology - 26/07/2018

Read more

Reverse Science Café: What are biobanks?

Read more

Persbericht - Life Sciences & Biotechnologie - 10/08/2018

Read more

Press Release - Life Sciences & Biotechnology - 10/08/2018

Read more

Deep Dive - 22/11/2018

Read more

UNDER EMBARGO UNTIL 1 AM CET, DECEMBER 18th, 2018

Read more

Invitation: flanders.health workshop & Life-on-chip event

Read more

Networking - 04/04/2019, Brussels

Read more

Survey

Read more

first flanders.health ideation workshop on Disease prevention

Read more

Invite: programme for future BioBusiness Leaders in Life Sciences & Health

Read more

Friendly reminder: programme for future BioBusiness Leaders in Life Sciences & Health

Read more

flanders.bio supports Healthy Ideas, Healthy Returns

Read more

State of the Union

Read more

Questionnaire: lifelong learning for Industrial Engineers Biochemistry

Read more

Invitation for flanders.bio's General Assembly

Read more

Last call: programme for future BioBusiness Leaders in Life Sciences & Health

Read more

Public Outreach

Read more

Regional scientific associations bring together researchers from industry and universities

Read more

Only a few places left: programme for future BioBusiness Leaders in Life Sciences & Health

Read more

Leuvense software zorgt voor wereldprimeur in de VS

Read more

Pilot call for PERSONALISED MEDICINE ICON projects opened (closing date 27/08/2019)

Read more

Registration open for the flanders.health partnering event on Personalised Medicine (28/05)

Read more

Invitation: Science for health (11/09/2019, Square Brussels)

Read more

Reminder: Science for health (11/09/2019, Square Brussels)

Read more

Zoekresultaten

Read more

flanders.bio networking: Smart Implant & (Bio-)medical Imaging Platform Meeting

Read more

flanders.bio internationalisation: BIO-EUROPE 2017

Read more

flanders.bio Expert Session: Quality - is it fit for the future?

Read more

BIO INTERNATIONAL CONVENTION 2018

Read more

7/12/2017

Read more

flanders.bio - Pitching Competition

Read more

Thank you for attending the latest flanders.bio-Janssen Partner Day

Read more

Information regarding Belgian biobank law and international standards

Read more

Press Release - Life Sciences & Biotechnology - 23/05/2018

Read more

Services

Read more

Launch MBI LS&Health 2018 - 2019

Read more

Last Call for flanders.bio's General Assembly

Read more

Follow-up information General Assembly flanders.bio

Read more

The FAMPH has published the Compendium on Biobank legislation

Read more

Information sessions regarding Belgian biobank law and international standards

Read more

Press Release - Life Sciences & Biotechnologie - 26/10/2018

Read more

Dirk Reyn benoemd als voorzitter van de Raad van Bestuur van flanders.bio

Read more

BIO INTERNATIONAL CONVENTION 2019

Read more

Invitation: Life-on-chip event

Read more

flanders.health Personalised Medicine event

Read more

flanders.health Personalised Medicine event (28/11, Leuven)

Read more

Ontwikkeling van nieuw geneesmiddel tegen leishmaniasis krijgt EU-financiering

Read more